Socioeconomic status as a correlate of plasma inflammatory markers: An association that may be modulated by the Interleukin-6 (-174)G/C promoter polymorphism by Petersen, Karen Laura
 SOCIOECONOMIC STATUS AS A CORRELATE OF PLASMA INFLAMMATORY 
MARKERS: AN ASSOCIATION THAT MAY BE MODULATED BY THE 
INTERLEUKIN 6 (-174) G/C PROMOTER POLYMORPHISM 
 
 
 
 
 
 
 
 
by 
Karen Laura Petersen 
BA, Wellesley College, 1996 
MS, University of Pittsburgh, 2003 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
University of Pittsburgh in partial fulfillment  
of the requirements for the degree of 
 Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
 
 
2007 
UNIVERSITY OF PITTSBURGH 
ARTS AND SCIENCES 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Karen Laura Petersen 
 
 
 
It was defended on 
June 29, 2007 
and approved by 
 
Robert Ferrell, PhD, Professor, Department of Public Health 
J. Richard Jennings, PhD, Professor, Department of Psychiatry and Psychology 
Anna L. Marsland, RN, PhD, Assistant Professor, Department of Psychology 
Matthew F. Muldoon, MD, MPH, Associate Professor, Department of Medicine 
Dissertation Chair: Stephen B. Manuck, PhD, Professor, Department of Psychology 
 ii 
SOCIOECONOMIC STATUS AS A CORRELATE OF PLASMA INFLAMMATORY 
MARKERS: AN ASSOCIATION THAT MAY BE MODULATED BY THE 
INTERLEUKIN 6 (-174) G/C PROMOTER POLYMORPHISM 
 
Karen L. Petersen, PhD 
University of Pittsburgh, 2007
 
Growing evidence suggests that socioeconomic attributes of both individuals and 
communities of residence confer risk for cardiovascular morbidity and mortality. Despite 
decades of research demonstrating worse health behavior profiles with lower levels of SES, 
unexplained variance in the association between SES and cardiovascular disease persists. In this 
study, we examined the association between both individual and community SES and 
inflammatory markers relevant to cardiovascular pathophysiology (i.e. interleukin-6 and C-
reactive protein) in a diverse sample of healthy community volunteers. We also examined 
whether a previously identified functional single nucleotide polymorphism on the IL-6 gene (-
174 G>C) is associated with IL-6 and CRP in this sample, and whether it moderates any 
influence of SES on these inflammatory markers. Subjects were middle-aged men and women 
(m=424, f=427; Caucasian=76.7%, African-American=22.8%) from the Adult Health and 
Behavior Project. Individual SES was indexed by averaging educational attainment and family 
income, and community SES was a composite of five variables from the participants’ US Census 
tract of residence. Regression analyses accounting for age, sex, and race showed individual SES 
to be associated with IL-6 (B=-.126, p < .001) and community SES to predict both IL-6 and CRP 
(B= -.163, p <.0001, B= -.129, p = .002, respectively). The inverse relationship between 
community SES and both inflammatory mediators persisted on multivariable adjustment for 
health behaviors (smoking, alcohol consumption, sleep, exercise, body mass index) and 
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individual SES (IL-6: B=-.091, p = .028 and CRP: B = -.086, p = .027). The relationship between 
individual SES and IL-6 did not withstand health behavior adjustment. Genetic analyses on the 
Caucasian subsample showed GG homozygotes to have lower CRP than participants with any C 
allele (i.e. GC & CC; t622=2.00, p <.05), but genotype by SES interactions were not significant. 
In sum, our results show that regardless of individual income, educational attainment, or -174 
G>C genotype, mid-life adults living in less advantaged neighborhoods have higher levels of 
circulating proinflammatory markers than residents of more affluent areas. This inflammation 
could mediate the association between lower community SES and atherosclerotic cardiovascular 
morbidity and mortality. 
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1.0  INTRODUCTION 
It is well established that relative social and economic disadvantage increases risk for diverse 
health outcomes, including most major sources of population morbidity and mortality (e.g. 
Adler, Boyce, Chesney, Folkman & Syme, 1993; Adler et al., 1994; Adler & Ostrove, 1999).  
Despite an abundance of research, the mechanisms responsible for such associations are not well 
understood.  Conceptually, socioeconomic position reflects one’s ranking within a larger social 
structure, and this structure might conceivably affect health in a variety of ways. For example, 
variation in socioeconomic strata gives rise to differential access to preventative and health care 
resources and disparate levels of exposure to adverse (health-impairing) conditions of living 
(Lynch & Kaplan, 2000).   Abundant speculation also exists surrounding stress and various 
neuroendocrine reactions to stressful life experiences, which may vary with socioeconomic 
position, contribute to disease etiology, or reflect a common biological process related to 
multiple health risks (e.g. McEwen, 2000).  Whatever the mechanisms, however, any hypothesis 
to explain the relationship between socioeconomic position and health must be derived, at least 
in part, from a conceptualization of socioeconomic status itself.  The purpose of this section of 
the paper, then, is to provide a context for the conceptualization of socioeconomic status, 
followed by a review of the research demonstrating an association between SES and 
cardiovascular disease.   
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1.1 CONCEPTUALIZATION OF SOCIOECONOMIC STATUS 
Lynch & Kaplan (2000) summarize three sociological traditions that give rise to divergent ways 
of conceptualizing contemporary social stratification.  Marxist theory is based on the notion that 
the class structure of a society arises out of a relationship between people and the production of 
commodities.  This theory is essentially a structuralist view, positing that a person’s social 
position (or social class) is dependent on his or her role in economic production.  According to 
Marx, then, exploitation by owners generates distinct classes that are inherently in opposition to 
each other in a capitalist society.  In contrast, Weber proposed an individualist perspective on 
social stratification that has also been highly influential in sociological thinking.  Weber 
suggested that capitalism created different “life chances” for individuals.  In Weberian sociology, 
the productive structure of society creates a systematically different distribution of resources, 
such as education, skills, assets, and opportunities that, in turn, contribute to an individual’s 
likelihood of accruing wealth and attaining membership in any particular stratum of society.  A 
third sociological tradition that has helped to shape current conceptualizations of socioeconomic 
status is the Functionalist perspective.  Functionalists argue that because complex societies 
require diverse trades and skills (some trades requiring more skills than others), social 
stratification is, in a sense, inevitable. Although each employee class is important in such a 
society, compensation and esteem vary according to position type.    
 The conceptualization of socioeconomic status in most of the social sciences 
today relies heavily on these sociological traditions, particularly the Weberian school of thought.  
Thus, modern “measures” of socioeconomic position often attempt to quantify an individual’s 
“life chances” by reference to income, educational attainment, occupation, or some combination 
of these factors.  Education, in particular, may relate significantly to a person’s “chances” of 
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succeeding in society, whereas income may better reflect the degree to which an individual has 
succeeded.  Occupation functions as the connection between education and income.  Presumably, 
all three of these factors correspond significantly with access to important resources and 
exposure to adverse conditions of life, with potential effects on health outcomes.  In turn, these 
indices of “life chances” can be understood as an extension of political and economic structures.  
Recently, it has become apparent that analogous features of the social environment, such as the 
average income, educational attainment, and unemployment levels of an individual’s community 
of residence, also contribute to disease risk (including that for cardiovascular disease) and may 
do so independently of individual level socioeconomic status (reviewed in Robert, 1999).  
Therefore, measures of socioeconomic status at the level of the community (neighborhood, 
census tract, postal code areas) provide additional information regarding the effects of variation 
in social and economic resources on health and will be considered as a unique measure of 
socioeconomic status in this paper. 
1.2 SOCIOECONOMIC STATUS AND CARDIOVASCULAR DISEASE 
A graded, inverse association exists between individual socioeconomic position and 
cardiovascular disease in industrialized, Western societies (Adler & Ostrove, 1999).  This 
relationship exists irrespective of gender, race, or the index of individual socioeconomic status 
that is used (income, education, occupation, or a composite of these measures) (reviewed in 
Kaplan & Keil, 1993; Pickering, 1999).  Variation in socioeconomic status is inversely related to 
both coronary heart disease (e.g.  Cassel et al., 1971; Keil, Loadholt, Weinrich, Sandifer & 
Boyle, 1984; Liu et al., 1982; Lynch, Krause, Kaplan, Tuomilehto, & Salonen, 1997; Pocock, 
 3 
Sharper, Cook, Phillips & Walker, 1987; Rose & Marmot, 1981; Siegel et al., 1987; Woodward, 
Shewry, Smith & Tunstall-Pedoe, 1992) and incidence of cardiovascular mortality (e.g.  Keil, 
Sutherland, Knapp & Tyroler, 1992; Lynch et al., 1997; Rose & Marmot, 1981; Salonen, 1982; 
Virtanen & Notkola, 2002; Williams et al., 1992).  Variation in socioeconomic indicators has 
also been associated inversely with both survival and ability to return to work following an acute 
cardiovascular event (e.g. Pell & D’Alonzo, 1964; Ruberman, Weinblatt, Goldberg, & Chaudary, 
1984; Smith & O’Rourke, 1988; Weinblatt, Shapiro, Frank & Sager, 1966; Williams et al., 1992; 
Young, Waller, & Kahana, 1991).   Finally, low childhood socioeconomic status predicts 
ischemic heart disease, including myocardial infarction and coronary death, in adulthood 
(Kaplan & Salonen, 1990; Notkola, Punsar, Karvonen & Haapakoski, 1985). 
As mentioned previously, area level indices of socioeconomic status are also used in 
predicting health outcomes.  Research indicates that inferior community socioeconomic 
characteristics predict greater cardiovascular morbidity (Eachus et al., 1996) and higher rates of 
coronary heart disease mortality (Eames, Ben-Shlomo, & Marmot, 1993).  Importantly, recent 
work incorporating both individual and community SES reveals a unique contribution of area 
SES to cardiovascular outcomes (Waitzman & Smith, 1998; Smith et al., 1988; Diez-Roux et al., 
1997; Diez-Roux et al., 2001; Hart et al., 1997).  For example, cardiovascular mortality rates 
were inversely related to community SES, a relationship that remained significant after 
controlling for individuals’ social class (Waitzman & Smith, 1998; LeClere, Rogers, & Peters, 
1998).  Prevalence of coronary heart disease (based on electrocardiographic indicators, history of 
coronary heart surgery or balloon angioplasty, or physician diagnosed myocardial infarction) and 
incidence of coronary events (probable myocardial infarction resulting in hospitalization, death 
due to coronary heart disease, or myocardial infarction documented as a change in ECG) were 
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also generally worse for those individuals living in lower SES communities, irrespective of 
individual indicators of SES (Diez-Roux et al., 1997; Diez Roux et al., 2001).  
These literatures show that both individual and community measures of socioeconomic 
status are important predictors of the symptomatic expression of cardiovascular disease (i.e. 
angina pectoris, myocardial infarction, arrhythmogenesis, or sudden cardiac death).  Recent 
work, however, indicates that SES is also important in the pathogenesis of cardiovascular 
disease.  Individual SES predicts preclinical carotid and aortic atherosclerosis, as indicated by a 
greater thickening of the intimal and medial layers of the artery wall (Diez-Roux, Nieto, Tyroler, 
Crum & Szklo, 1995; Lynch, Kaplan, Salonen, Cohen & Salonen, 1995; Gallo, Matthews, 
Kuller, Sutton-Tyrrell & Edmundowicz, 2001; van Rossum, van de Mheen, Witteman, 
Mackenbach, & Grobbee, 1999).   Variation in arterial elasticity is inversely associated with 
educational achievement in the four-site Atherosclerosis Risk in Communities (ARIC) study 
(Din-Dzietham et al, 2000), and, finally, individual educational attainment and income are 
associated with progression of carotid artery atherosclerosis in men with and without ischemic 
heart disease over a four-year period (Lynch, Kaplan, Salonen & Salonen, 1997).  Community 
SES has also been shown to independently predict plaque occurrence in hypertensive men 
(Petersen et al, 2006.)  
1.2.1 Mediators of the SES-cardiovascular disease relationship 
Despite significant findings linking socioeconomic status to both preclinical cardiovascular 
disease and clinical events associated with more advanced stages of the disease, how 
socioeconomic status might be associated with these outcomes remains unclear.  Variation in the 
socioeconomic attributes of both individuals and areas is associated with many adverse health 
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behaviors and cardiovascular risk factors.  Lower community SES is associated with worse 
dietary habits of youth (Lee & Cubbin, 2002), increased smoking behavior (Smith et al., 1998; 
Diez-Roux, 1997; Reijneveld et al., 1998; Sundquist et al., 1998; Duncan et al., 1999), and 
decreased physical activity levels (Sundquist et al., 1998, Yen & Kaplan, 1998).  Variation in 
physiological risk factors is also associated with socioeconomic characteristics.  Left-ventricular 
mass and reactivity to stress are inversely related to community socioeconomic status in African-
American children (Gump, et al., 1999).  Also, higher systolic blood pressure is associated with 
both community and individual SES (Diez-Roux et al., 1997; reviewed in Pickering, 1999); 
greater airway resistance, higher BMI and obesity, and anginal symptoms are related to worse 
community quality (Diez-Roux et al., 1997; Smith et al., 1998; Sundquist et al., 1998).  The 
association between cholesterol levels and socioeconomic status is less clear.  One study shows 
some variation in cholesterol levels to be attributable to district of residence (Hart et al., 1997), 
another study suggests community SES is related inversely to cholesterol levels in 3 out of 4 
ARIC test sites (Diez-Roux et al., 1997), and a final study does not report a significant, 
independent association between cholesterol levels and community SES (Smith et al., 1998).  
Results for individual SES and cholesterol are similarly mixed (reviewed in Pickering, 1999). A 
modest inverse association exists with individual SES and infection from bacteria and virus 
strains hypothesized to play a role in the pathogenesis of cardiovascular disease (e.g. Go, 2002; 
Romeo et al., 2001). 
Adverse socioeconomic conditions are also associated with multiple psychosocial risk 
factors for cardiovascular disease. These risk factors include personality characteristics like 
hostility, hopelessness, and feelings of perceived control and mastery, and psychopathology, 
such as more prevalent depression in lower SES individuals (e.g. Rozanski et al., 1999). Lower 
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SES appears to be associated with significantly more chronic stress, as measured and 
conceptualized in multiple ways. For example, lower SES is associated with more environmental 
challenges (Baum et al., 1999), fewer coping resources to deal with these challenges (Rosengren 
et al., 1998), greater job strain (including greater effort and lower reward as SES declines; e.g. 
Bosma et al., 1998), and greater measures of chronic life stress (i.e. health problems of 
significant others, problems with living conditions, financial stressors; Lynch et al., 1997). 
Related measures in community environments show that more stressful life events such as job 
loss and criminal victimization are reported in areas with more adverse socioeconomic 
conditions. Finally, social support, social integration, and social isolation are all worse in lower 
SES environments (e.g. Turner & Marino, 1994).  
1.3 INFLAMMATION 
1.3.1 Background 
In most studies, multivariate adjustment for the aforementioned risk factors weakens, but 
does not eliminate, the graded relationship between socioeconomic status and cardiovascular 
morbidity and mortality (reviewed in Kaplan & Keil, 1993; Gallo et al., 2001; Lynch et al., 1995; 
Diez-Roux et al., 1995; Din-Dzietham et al., 2000; Gallo et al., 2001; Lynch et al., 1995; Diez-
Roux et al., 1995, van Rossum et al., 1999). Thus, other factors must contribute to this 
relationship. One possible candidate is inflammation, which has recently been shown to be a risk 
factor for the development and exacerbation of atherosclerosis.  
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 Prior to the 1990s, atherogenesis was thought to involve the passive accumulation 
of lipids in arterial walls, leading to progressive occlusion of the vessel and associated symptoms 
of cardiovascular disease.    More recent models propose that inflammation plays a primary and 
essential role in atherogenesis and thus the incidence and course of CVD (e.g., Ross, 1999). In 
these models, the immune system is activated in response to vascular injury, i.e. from oxidized 
low density lipoproteins, free radicals (e.g. from smoking), hemodynamic perturbations, elevated 
plasma homocysteine, or infectious microorganisms. The inflammatory response should work to 
remove the offending agent and repair the tissue, but if the agent is not removed, the theory 
states that the inflammatory response will persist, activate portions of the adaptive immune 
response (i.e. T-cells) and become a chronic problem, rather than a solution.  The result is a 
fibroproliferative process that leads to obstruction, and eventually to the development of 
vulnerable, complicated plaques with potential for rupture and thrombosis. 
 In a  healthy artery leukocytes rarely attach to the endothelium.  In response to  
injury , the endothelium expresses adhesion molecules that bind leukocytes and platelets.  This 
leukocyte adherence is, presumably, the first stage of the response to injury.  An increased 
permeability of the endothelium allows leukocytes to migrate into the intima through gaps 
between endothelial cells, initiating a localized inflammatory response.  Here, monocytes mature 
into macrophages that express scavenger receptors for ingesting modified lipoproteins, and the 
foam cell is formed.  In the continued presence of injury, multiple foam cells form and result in 
the earliest atherosclerotic lesion, the fatty streak.  Activated macrophages proliferate within the 
lesion and release multiple pro-inflammatory cytokines, chemoattractants, growth factors, and 
hydrolytic enzymes, perpetuating this localized inflammatory response.  If the response persists, 
it is thought that a fibrofatty plaque, with a necrotic, lipid-laden core, containing multiple layers 
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of smooth muscle cells, connective tissue, macrophages and T-lymphocytes develops.  Processes 
of repair yield a fibrous cap that contains the lesion until sufficient macrophages accumulate. It is 
thought that this accumulation of macrophages erodes or thins the fibrous structure and leaves 
the plaque vulnerable to rupture (Ross, 1999; Libby, 2002; Libby, Ridker, & Maseri, 2002).   
Research supporting this theory has proliferated in the last decade, and evidence now 
exists from several different lines of investigation to suggest a role for inflammation in the 
pathobiology of cardiovascular disease. Epidemiological evidence from diverse populations 
shows inflammatory markers, such as pro-inflammatory cytokines (e.g. IL-6, tumor necrosis 
factor-alpha, etc) and acute phase reactants (e.g. C-reactive protein, fibrinogen), to predict future 
cardiovascular events and mortality (e.g. Rattazzi, Puato, Faggin, Bertipaglia, Zambon, & 
Pauletto, 2003; Biasucci et al., 1996; Biasucci et al., 1999; Ridker, Rifai, Stampfer, & 
Hennekens, 2000; Pradhan et al., 2002, Ridker, Hennekens, Buring, & Rifai, 2000; Harris et al., 
1999; Danesh et al., 2000; Danesh et al., 2004; Lagrand et al., 1999). Inflammatory markers, 
including cytokines, macrophages and T-cells, are present in all types of atherosclerotic lesions, 
from early foam cells to complicated lesions (Napoli et al., 1997; Stary et al., Schonbeck et al., 
1997). Finally, data from the animal and in-vitro literatures provide the strongest evidence for a 
role of inflammation in cardiovascular disease. For example, mice genetically engineered to 
express human CRP show 34-48% greater lesion development compared to wild type mice (Paul 
et al., 2004), and transgenic mice that are deficient in monocyte chemoattractant protein-1 or its 
receptor show decreased lesion formation (Boring, Gosling, Cleary, & Charo, 1998; Gu et al., 
1998). Mice engineered to produce significantly less vascular cell adhesion molecule-1 (i.e. 2-
8% of wild type mice levels) show a reduction in atherosclerotic lesion development (Cybulsky 
et al., 2001).  In later stages of the disease, activated macrophages have been shown to produce 
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enzymes that degrade the extracellular matrix leaving plaques more vulnerable to rupture 
(Nikkari et al., 1995; Galis, Sukhova, Kranzhofer, Clark, & Libby, 1995), and transgenic mice 
that express human CRP are at increased risk of thrombosis after mechanical vascular injury 
(Danenberg et al., 2003). The research from the animal and in-vitro literatures support the 
hypotheses generated from epidemiological research to suggest that inflammatory cells are not 
just markers of existing disease, but also function in a pathogenic role.  
 
1.3.2 Interleukin-6.  
Interleukin-6 (IL-6), a pro-inflammatory cytokine, is of particular interest because it is one of the 
best-documented indices of inflammation. IL-6 is induced primarily by another pro-
inflammatory cytokine, interleukin-1. Multiple cell types are credited with producing IL-6 (i.e. 
vascular smooth muscle cells, adipose cells, monocytes, macrophages, lymphocytes, endothelial 
cells, fibroblasts, mast cells, astorcytes, microglia, osteoblasts, bone marrow stromal cells, 
keratinocytes, synoviocytes, chondrocytes, epithelial cells, folliculostellate cells of the pituitary, 
endometrial stromal cells, and trophoblasts). The multiple functions of IL-6 include, but are not 
limited to, induction of the acute phase response (i.e. stimulation of CRP and fibrinogen), 
differentiation and maturation of B cells (including inducing production of immunoglobulin), 
and proliferation and differentiation of T cells (Papanicolaou, Wilder, Manolagas, & Chrousos, 
1998; Le & Vilcek, 1989.)   
Prospective evidence shows higher levels of IL-6 in patients with unstable versus stable 
angina, and levels of IL-6 upon hospital admission predict coronary events (Biasucci et al., 1996; 
Biasucci et al., 1999).  Importantly, large scale, prospective studies in presumably healthy men 
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(Ridker, Rifai, Stamnpfer, & Hennekens, 2000), post-menopausal women (Pradhan et al., 2002; 
Ridker, Hennekens, Buring, & Rifai, 2000), and older adults (Harris et al., 1999) show that 
elevated basal levels of IL-6 predict future cardiovascular events and mortality.  Relative risk for 
mortality or incident CHD for those in the highest quartile of baseline IL-6 versus the lowest 
quartile ranged from 1.9 to 2.3 (Ridker et al., 2000; 2000b; Harris, 1999), and odds ratio for 
incident CHD in post-menopausal women was 3.3 (Pradhan et al., 1999) in these studies. After 
controlling for traditional risk factors (Harris et al., 1999, Pradhan et al., 2002, Ridker et al., 
2000b) and other inflammatory markers (including C-reactive protein; Ridker et al., 2000b; 
Harris et al., 1999) the risk remained significant in most studies.  
1.3.3 SES and Interleukin-6. 
Currently five published studies examine the relationship between socioeconomic status and IL-6 
(Woodward et al., 1999; Yudkin et al., 1999; Brydon et al, 2004; Steptoe et al., 2002; Mendall et 
al., 1997), albeit with inconsistent results. One study shows urban slum dwellers in India to have 
higher levels of IL-6 than residents of middle class neighborhoods, although it is unclear whether 
data were adjusted for concomitant infection, a likely correlate of living in congested areas of 
socioeconomic disadvantage (Yudkin et al., 1999). An analysis of a subsample of the Whitehall 
II cohort showed occupation levels in England (in women only) to be associated with IL-6. In 
this study, the lowest levels of IL-6 were found in the highest employment grade, but the 
findings were non-linear and there were no differences in men (Steptoe et al., 2002). Childhood 
SES, based on father’s occupation type, was also inversely associated with IL-6, but the subjects’ 
own occupation was not a significant predictor (Mendall et al., 1997).  Two other investigations 
report no differences in IL-6 levels based on occupation type; although the sample size in one of 
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these studies was extremely small, limiting the study’s power to reject null findings (n=38) 
(Woodward et al., 1999; Brydon et al., 2004). Finally, preliminary analyses involving 501 
healthy Caucasian and African-American participants in the University of Pittsburgh Adult 
Health and Behavior Project (AHAB) showed a composite index of income and educational 
attainment to be inversely associated with IL-6 levels (r = -.16, p <.01) (Petersen et al., 2005). In 
sum, the few data regarding potential associations between SES and inflammatory markers are 
inconsistent and subject to a variety of methodological deficiencies (restricted sample sizes, 
dissimilar indices of social inequalities). Nonetheless, the AHAB findings, which are based on a 
reasonably large community sample and employ conventional indicators of socioeconomic 
position, along with the Whitehall II findings, offer promising evidence of at least a modest 
inverse association between SES and inflammation.  
1.3.4 C-Reactive protein. 
C-reactive protein (CRP) is perhaps the most frequently cited inflammatory marker in 
epidemiological studies showing an association between inflammation and cardiovascular 
outcomes.  It is also the inflammatory marker that has been widely promoted as having clinical 
utility in establishing cardiovascular risk levels, suggesting that levels less than 1.0 mg/L 
represent low risk, 1.0-3.0 mg/L mid-level risk, and levels greater than 3.0 mg/L represent high 
risk for subsequent cardiovascular disease complications (Ridker, 2003; Pearson et al., 2003).   
As previously mentioned, CRP is an acute phase reactant that is induced by IL-6 and other pro-
inflammatory cytokines (i.e. IL-1 and TNF-α).  CRP is produced in cells of the liver, 
atherosclerotic lesions (by macrophages and smooth muscle cells), the kidney, neurons and 
macrophages in the alveoli (Jialal, Devaraj, & Venugopal, 2004).  As part of the innate immune 
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response, the biological roles of CRP include activation of the classical complement immune 
pathway, which allows for elimination of cellular debris or infectious elements (Rattazi et al., 
2003.) 
Multiple recent review articles and meta-analyses of the literature investigating the role 
of CRP in cardiovascular disease show consistent evidence of the utility of CRP to predict future 
cardiovascular morbidity and mortality (Danesh et al., 2000; Danesh et al., 2004; Lagrand et al., 
1999) differentially from total mortality (Tice et al., 2003).  For example, in a 1999 review of 17 
different studies, Lagrand and colleagues cite several studies showing that CRP predicts 
cardiovascular events in apparently healthy people and several studies showing the rise in CRP 
after myocardial infarction to predict future cardiovascular events in patients with unstable 
angina. Danesh and colleagues conducted a meta-analysis of 14 prospective studies of mostly 
middle-aged, healthy men.  Those men with baseline CRP levels in the top third compared to 
men with levels in the bottom third produced an odds ratio of 1.9 (95% CI = 1.5, 2.3) for incident 
coronary heart disease (Danesh et al., 2000).  A 2004 meta-analysis including the original studies 
(from the 2000 paper) and an additional 12 studies produced a slightly lower, but still significant, 
odds ratio of 1.5 (95% CI = 1.48, 1.68) for people in the top third versus the bottom third of 
baseline CRP levels (Danesh et al., 2004).  The individual studies had taken into account 
standard risk factors for cardiovascular disease. 
1.3.5 SES and C-Reactive Protein 
Six studies examined the association between a measure of socioeconomic status and C-reactive 
protein in cross-sectional designs (Owen et al., 2003; Jousilahti et al., 2003; Panagiotakos et al., 
2004; Mendall et al., 2000; Danesh et al., 1999; and Wu et al., 2002) and all studies provide 
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some evidence that socioeconomic status is inversely related to CRP levels.  In a healthy, 
Caucasian subsample of the Whitehall II study of male and female British civil servants, subjects 
in low vs. high occupational groups were more likely to have a CRP reading greater than 1.0 
mg/l (OR = 2.85), even after accounting for multiple confounding factors such as age, BMI and 
smoking status (Owen et al, 2003).  This number is particularly significant because prospective 
cardiovascular studies have shown that CRP levels above 1.0 mg/L represent moderate to high 
risk for subsequent cardiovascular disease complications (Ridker et al, 2003; Pearson et al., 
2003).   These findings extend to a population based study of Finnish men (including men with 
chronic disease), where higher levels of CRP were found in groups with a lower composite SES 
score (based on income and education), even after accounting for presence of disease and other 
inflammatory risk factors (Jousilahti et al., 2003).  Educational attainment was also inversely 
associated with CRP levels in a Greek sample (Panagiotakos et al., 2004) and in a multiracial 
sample (84% Caucasian, 11% African American and 5% Hispanic) (Wu et al, 2002). Finally, 
employment status (employed/unemployed; Danesh et al, 1999) and childhood SES based on 
father’s occupation (manual/non-manual laborer; Mendall et al, 2000) were associated with CRP, 
such that lower SES predicted higher CRP levels.  Several markers of SES used within these 
same studies did not predict CRP levels, however, including measures of car and home 
ownership, one measure of educational attainment (Danesh et al.), and manual employment of 
the individual (Danesh et al.; Mendall et al, 2000).  In summary, however, the majority of 
evidence shows that SES is inversely related to CRP levels, even after controlling for known 
covariates. 
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1.3.6 Risk factors for heightened inflammation. 
Levels of inflammatory cytokines and acute phase reactants can vary among individuals for a 
number of reasons. For example, age and obesity are positively associated with multiple 
measures of inflammation, including IL-6 and CRP (Bermudez, Rifai, Buring, Manson, & 
Ridker, 2002; Fernandez-Real et al., 2001; Mohamed-Ali et al., 1997; Ridker, Hennekens, 
Buring, & Rifai, 2000; Yudkin et al., 1999; reviewed in Kaplan & Fishmann, 2001). Adipose 
tissue produces pro-inflammatory cytokines, and weight reduction results in decreased levels of 
Il-6 (Tchernolf et al., 2002; Esposito et al., 2003). Other factors affecting inflammatory activity 
include high blood pressure, smoking, hyperlipidemia, insulin insensitivity and diabetes, physical 
inactivity, and chronic infection (Bermudez et al, 2002; Fernandez-Real et al., 2001; Mohamed-
Ali et al., 1997; Ridker et al, 2000; Kaplan & Frishmann, 2001). Smoking and hyperlipidemia 
both cause endothelial dysfunction from oxidative stress (Altman, 2003). Hyperglycemia, a 
result of insulin insensitivity and/or diabetes, results in the production of advanced glycation 
end-products (AGE), which trigger endothelial dysfunction and the expression of 
proinflammatory molecules (Evan, Khan, & Rees, 1999). Acute physical activity can enhance 
the expression of inflammatory cells; however, routine, moderate physical activity is associated 
with lower levels of circulating pro-inflammatory cytokines (e.g. Taaffe, Harris, Ferrucci, Rowe 
& Seeman, 2000). Finally, chronic infection may function as an irritant stimulating a low level, 
chronic inflammatory response (as in the case of C. pneumoniae and cytomegalovirus) or by 
directly infecting the vessel wall (as in the case of H.  pylori; Abgueguen, Delbos, Chennebault, 
Payan, & Pichard, 2003; Go, 2002; Griffiths & Emery, 1999; reviewed in Romeo, Clementi, 
Saldeen, & Mehta, 2001). 
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1.4 GENETIC INFLUENCES ON INFLAMMATORY MARKERS 
1.4.1 Quantitative Genetic Studies. 
While the risk factors for elevated inflammation mirror those of cardiovascular disease and are 
known to cluster in individuals of lower SES, the relationship between SES and inflammation is 
still quite modest (i.e. IL-6: r = -.16, p < .01 in AHAB). It is likely that heritable factors also 
contribute to inflammation, such that only individuals of lower SES harboring a certain genotype 
exhibit higher levels of IL-6 or CRP (i.e. gene by environment interaction).  Recently, four 
quantitative genetic studies have examined relative genetic and environmental influences on IL-6 
levels.  Two such studies, one twin study and one non-twin family study, show the heritability of 
baseline plasma IL-6 levels to range from 17-24% (Pantsulaia, Trofimov, Kobyliansky, & 
Livshits, 2002; de Maat, Bladbjerg, Hjelmborg, Bathum, Jespersen, & Christensen, 2004). Two 
other quantitative studies examined the genetic influences of stimulated IL-6 levels, i.e. after ex-
vivo stimulation by either lipolysaccharide (LPS) or amyloid-B. Both studies were of a twin 
design and showed high heritability for stimulated levels of IL-6 (57-67%) (de Craen, Posthuma, 
Remarque, van den Biggenlaar, Westendorp & DI Boomsma, 2005; Posthuma, Meulenbelt, De 
Craen, Geus, Slagboom, Boomsma, & Westendorp, 2005).  
1.4.2 Molecular Genetic Studies 
Several polymorphisms within the IL-6 gene have been examined to account for variation in IL-6 
levels and disease susceptibility. The IL-6 gene is located on the short arm of chromosome 7 (p-
15), and contains 5 exons and 4 introns.  Functional variation in IL-6 levels has been attributed to 
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sites within the 5’ flanking region of the IL-6 gene promoter. Here several single nucleotide 
polymorphisms (SNP) have been identified, including those at nucleotides -597 (G>A), -572 
(G>C), -174 (G>C), and a variable AnTn tract at –392 to –373; all of which are in strong linkage 
disequilibrium (Fishman et al, 1998; Terry, Loukaci & Green, 2000). Haplotype analyses reveal 
that although multiple SNPs function in the regulation of IL-6 expression, the -174 G>C SNP, 
located 1.2 kb upstream from the start of transcription, may be important since endothelial-like 
cells transfected with haplotypes including the -174 G-allele showed the highest transcriptional 
activity, irrespective of the other alleles in the haplotype (Terry et al., 2000). In this same study, 
however, hepatic cell lines showed a different pattern of results, suggesting that the regulation of 
IL-6 expression is a complex interaction of multiple SNPs and may vary in different types of 
tissue (Terry et al., 2000).  Some evidence from an ex-vivo LPS stimulation of leukocytes 
supports the importance of the 174 G>C SNP in regulating ILG, however, as -174-GG 
individuals expressed higher IL-6 levels irrespective of alleles at -597 or –572 (Rivera-Chavez, 
Peters-Hybki, Barber, & O’Keefe, 2003). 
Fishman (1998) reports the frequency of the less common C allele in Caucasians to be 
0.40 (95% CI: 0.37-0.44), and studies since then report similar frequencies in Caucasians (e.g. 
Burzotta et al., 2001, Heesen et al., 2002). Allele frequencies vary by ethnicity, however, with 
one study showing only 1.2% of African-American women to carry the CC genotype, compared 
to 18.8% of Caucasian women, while 82.5% of African American women carried the GG 
genotype compared to 36.3% of Caucasian women (Ness, Haggerty, Harger,, & Ferrell, 2004). In 
reporter gene constructs, the G allele was associated with greater expression of IL-6 both in 
unstimulated cells and in response to interleukin-1 and LPS (Fishman et al, 1998). More 
specifically, in unstimulated cells, the C allele was associated with 0.62-fold lower luciferase 
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expression than the G allele. In cells stimulated with IL-1 and LPS, a 4.38-fold and 4.55-fold 
increased expression, respectively, was associated with the G allele relative to the C allele 
(Fishman et al., 1998). Higher IL-6 production associated with the G allele has also been 
demonstrated in adherent peripheral blood mononuclear cells (Olivieri et al., 2002), but one 
study of LPS stimulation of whole blood showed inconsistent results, with the highest levels of 
IL-6 produced in GG or CC genotypes, and the lowest levels produced in heterozygotes (Heesen, 
Bloemeke, Heussen, & Kunz, 2002.) In sum, the majority of evidence from in vitro models 
suggests that the -174 G allele enhances transcription and expression of IL-6. 
In vivo studies examining plasma IL-6 levels by genotype report mixed findings. For 
example, plasma IL-6 levels were nearly twice as high in healthy Caucasians homozygous for 
the G allele vs. those with a CC genotype (Fishman et al, 1998). Serum IL-6 was significantly 
higher in men with a G allele (Olivieri et al., 2002) and in elderly men and women (Bonafe, 
2001), but no differences in baseline IL-6 by genotype have also been reported  (Endler, et al., 
2004; Jerrard-Dunne et al., 2003; Margalionie, Bossone, Cappucci, Colaizzo, Grandone, Di 
Minno, 2001; [subset of women] Olivieri et al., 2002). Of note, sample size limitations and 
sensitivity of the IL-6 assays may have been a factor in the null findings.  
Studies examining the association of the -174 G>C polymorphism and IL-6 levels in 
clinical populations and in regard to disease endpoints also show a complicated set of results. For 
example, no differences in IL-6 levels by genotype were reported in myocardial infarction (MI) 
patients (Bennermo et al., 2004; Lieb et al., 2004; Nauck, Winklemann, Hoffmann, Bohm, 
Wieland, & Marz, 2002), but the CC genotype was associated with higher IL-6 levels in patients 
with aortic aneurysm (Jones et al., 2001) and in heavy drinkers (Jerrard-Dunne et al., 2003). The 
presence of a G allele, however, was associated with higher plasma IL-6 levels in hemodialysis 
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patients (Balakrishnan et al., 2004). Further, the G allele or G homozygosity has also been shown 
to predict multiple adverse cardiovascular outcomes, including atrial fibrillation as a 
postoperative complication of coronary artery bypass grafting surgery (CABG) (Gaudino et al., 
2003), peripheral artery occlusive disease (Flex et al., 2002), severe stroke (Greisenegger et al., 
2003), mortality after coronary event (Antonicelli et al. 2005), adverse lipid profiles (Fernandez-
Real, 2000) and greater intima-medial thickness (IMT) (Rundek et al., 2001). Not all studies are 
in agreement, however, as some report greater cardiovascular risk to be associated with the C 
allele [i.e. plaque and IMT in heavy drinkers (Jerrard-Dunne et al., 2003); MI (Georges et al., 
2001); higher blood pressure and coronary heart disease (Humphries, Luong, Ogg, Hawe, & 
Miller, 2001)] or no association with the -174 G>C polymorphism [e.g. essential hypertension 
(Pola et al, 2002)]. 
 Because IL-6 is crucial in orchestrating the acute inflammatory response, several 
studies have examined acute changes in IL-6 levels as a function of genotype. The -174-GG 
genotype was associated with higher IL-6 levels after surgery in several studies, (Burzotta et al., 
2001; Travelyan, Brull, Needham, Montgomery, Morris & Mattu 2004; Gaudino et al. 2003), but 
one study reported no differences in peak IL-6 levels by genotype (Bown et al., 2003) and 
another reported differences in the timing of the peak IL-6 response by genotype (Brull et al., 
2001). The GG genotype was also associated with higher IL-6 levels after vaccination with the 
Salmonella typhi vaccine (Bennermo et al., 2004) and ex-vivo LPS stimulation of leukocytes 
(Rivera-Chavez et al., 2003). However, young, healthy males injected with LPS showed no 
difference in IL-6 response by genotype (Endler et al., 2004). In sum, the majority of these 
studies suggest that the -174 G>C polymorphism modulates an individual’s inflammatory (i.e. 
IL-6) response to an acute trigger, although the studies are not without contradiction. 
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Methodological differences between studies (i.e. timing of IL-6 measurement; sample 
characteristics) and limited statistical power (i.e. Endler et al., 2004; Bown et al., 2003) may 
account for some of the inconsistencies reported herein.  
Finally, several studies have examined the association between -174 G>C and circulating 
CRP levels, given the role of IL-6 in the induction of CRP production. These studies produce 
largely null findings, showing no differences in circulating CRP levels by genotype in male 
elderly patients with acute coronary syndrome (Antonicelli et al., 2005), patients with coronary 
heart disease (Latkovskis, Licis, & Kalnins, 2004), Type II diabetic patients (Abrahamian et al., 
2007), obese males (Eklund et al., 2006), or patients with an abdominal aortic aneurysm (Jones 
et al., 2001). However, another sample of Type II diabetes patients (Libra et al, 2006) and 
patients with severe periodontal disease (D’Aiuto, Parkar, Brett, Ready, Tonetti, 2004) having 
the GG genotype have also been shown to display higher levels of CRP. And while there was no 
difference in CRP levels related to the 174 G>C polymorphism in postmenopausal women, the -
572/-174 promoter haplotype was predictive of circulating CRP levels in these women (Ferrari, 
Ahn-Luong, Garnero, Humphries, & Greenspan, 2003), with carriers of the 174 G allele showing 
higher levels of CRP.  In sum, investigation of the 174 G>C polymorphism and circulating CRP 
levels has produced conflicting results. Many studies of patients with various illnesses (i.e. Type 
II diabetes, coronary heart disease, abdominal aortic aneurysm) have produced null findings, 
however, the majority of these studies had samples of less than 160 people. Two additional 
studies showed an association between 174 G>C and circulating CRP in periodontal patients and 
Type II diabetics, and one study showed that 174 G>C in combination with another site in the 
IL-6 promoter region (i.e. 572 G>C) was associated with variation in CRP levels.  
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1.4.3 Summary of genetic influences on IL-6 and CRP.  
In sum, quantitative genetic studies suggest variation in IL-6 to be heritable, with 
estimates ranging from 17-24% for basal IL-6 and 57-67% for stimulated levels of IL-6. In-vitro 
studies suggest that presence of the G allele, and G homozygosity in particular, may be 
associated with increased transcription of IL-6, however all studies are not consistent. In-vivo 
studies of baseline IL-6 levels in healthy humans suggest that expression of IL-6 is also higher in 
individuals carrying the G allele, and while all studies are not in agreement, discrepant findings 
may be attributable to sample characteristics (e.g. age or health status), or limited statistical 
power. Results from clinical samples (i.e. patients with abdominal aortic aneurysms, myocardial 
infarction patients) are more difficult to interpret with some studies showing no difference in IL-
6 levels by genotype, and some showing higher levels with the presence of the C allele. 
However, numerous studies show the -174 G>C polymorphism to be associated with distal 
cardiovascular phenotypes (e.g. IMT, plaque, atrial fibrillation, mortality).  Studies also suggest 
that the -174 G>C polymorphism moderates the IL-6 response to an acute challenge (i.e. surgery, 
LPS stimulation, vaccination), and the majority of the studies suggest that the G allele is 
predictive of a greater IL-6 response. In sum, evidence from in-vitro and in-vivo studies suggest 
that the -174 G>C polymorphism alters function of the IL-6 gene promoter, with the majority of 
studies suggesting that the G allele is associated with higher IL-6 expression. Further, evidence 
from in vivo challenge studies suggests that the acute IL-6 response is also modulated by the -
174 G>C polymorphism. Finally, studies examining the association between -174 G>C and CRP 
are conflicting, with several small studies showing no association, two studies showing G 
homozygosity to be associated with increased circulating CRP, and a final study showing the 
174/572 promoter haplotype to be associated with CRP. 
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1.5 PURPOSE OF THE PROPOSED STUDY 
Low socioeconomic status is associated with a myriad of adverse health conditions, 
including increased risk for cardiovascular disease. Despite numerous studies investigating 
potential mediating factors, the association between SES and cardiovascular disease remains 
largely unexplained. Inflammation is increasingly seen as a pathophysiological factor in the 
development and exacerbation of cardiovascular disease, and within this literature, two 
inflammatory markers, IL-6 and CRP, have emerged as prominent prognostic indicators. 
Accordingly, a few studies have begun to examine the potential for covariation between SES and 
these inflammatory markers. Results from these studies are inconsistent, with some support for 
an inverse association between SES and CRP, and two of the largest studies on SES and IL-6 
suggesting that a modest association may exist. The primary aim of this study is to expand upon 
an early finding from our laboratory that showed an index of individual education and income to 
be associated with IL-6 levels. In a larger, community based sample, we will examine the 
association of both individual and community SES with IL-6 and CRP.  
The preliminary individual SES-IL-6 finding in AHAB was modest (r = -.16, p <.01), and 
findings across studies are inconsistent. While multiple factors are known to influence 
circulating inflammatory markers (e.g. physical activity, alcohol consumption, smoking, etc.), 
quantitative genetic studies have also shown that a portion of interindividual variation in IL-6 is 
heritable. It is possible, therefore, that an association between SES and both IL-6 and CRP could 
be moderated not only by environmental exposure, but also by genetic influences. Thus, if the 
primary SES -IL-6 finding persists in the expanded sample and extends to CRP, a secondary aim 
of the paper will be to examine whether variation in a promoter polymorphism of the IL-6 gene 
(i.e. -174 G>C) modulates the influence of SES (both individual and community) on IL-6 and 
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CRP. Molecular genetic studies have identified a possibly functional single nucleotide 
polymorphism (-174 G>C) of the IL-6 promoter region. In vitro studies suggest the G allele may 
be associated with increased rates of IL-6 gene transcription, and results from studies in healthy 
individuals also suggest that the G allele is associated with higher levels of circulating IL-6. 
Finally, a gene by environment interaction has been demonstrated with the -174 G>C 
polymorphism, such that in vivo challenge by surgery and vaccination results preferentially in 
increased IL-6 levels among individuals possessing a G allele. It is possible that a more distal 
environmental stimulus (i.e. SES), then, might also be associated with higher IL-6 levels in 
individuals possessing the G allele, especially given the overall modest association between SES 
and IL-6 levels demonstrated in preliminary investigations. Since IL-6 stimulates the 
proinflammatory response and triggers the release of CRP, a few studies have evaluated the 
association between  -174 G>C and CRP. These studies show a conflicting pattern of results with 
both null findings and some evidence of increased circulating CRP in individuals carrying a G 
allele. In this study our hypotheses are as follows:  
1.5.1 Hypotheses: 
Hypothesis 1 – Independent of demographic covariates (age, sex, and race), IL-6 will be 
associated inversely with individual SES (defined by composite index of income and education); 
we expect this relationship to extend to CRP, as well. Community SES has been shown to predict 
health outcomes (including those associated with cardiovascular disease). Accordingly, 
community SES (an index derived from sociodemographic variables characterizing U.S. Census 
tracts of residence) will be inversely associated with IL-6 and CRP in this study.  
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Hypothesis 2 –In accordance with evidence showing community SES is associated with health 
outcomes independently of individual SES, we expect community SES to be independently 
associated with IL-6 and CRP in this study, after also adjusting for age, sex, and race.  
 
Hypothesis 3 –Assuming hypotheses 1 and 2 are supported, the extent to which any association 
between SES and IL-6/CRP may be independent of concomitant variability in other risk factors 
will also be determined (i.e. smoking, BMI, alcohol consumption, sleep, and physical inactivity).  
 
Hypothesis 4 – In accordance with in-vitro studies showing the G allele of -174 G>C to be 
associated with greater transcription of IL-6 and CRP, the G allele is expected to be positively 
correlated with circulating IL-6 and CRP concentrations.  
 
Hypothesis 5 – We expect a gene by environment interaction as follows: 
- In low SES participants (both individual level and community SES), the G allele will 
be associated with higher concentrations of IL-6 and CRP, but in high SES 
individuals there should be no differences in IL-6 or CRP concentrations based on 
genotype.   
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2.0  METHODS 
2.1 STUDY OVERVIEW 
This investigation included 1379 individuals between the ages of 30 and 54 who 
participated in the Adult Health and Behavior project (AHAB) between 2001 and 2005. AHAB 
is a University of Pittsburgh registry of diverse behavioral and biological measurements 
collected on individuals recruited (by mail solicitation) from communities of Southwestern 
Pennsylvania (principally Allegheny County).  Potential participants were excluded if they 
reported a history of any of the following conditions: myocardial infarction, stroke, or cancer 
treatment within the past year, chronic kidney or liver disease, major neurological disorders, 
schizophrenia or other psychotic illness. Pregnant women were also ineligible. Participants 
taking nitrates, digoxins, anti-arrhythmic medications, glucocorticoids, insulin, or weight-loss 
drugs were also excluded. Inflammatory assays were conducted on frozen plasma from 1081 
subjects from the larger AHAB database. Given that AHAB eligibility did not include absence of 
common acute illnesses (e.g., recent colds or allergies), IL-6 levels greater than 10pg/ml or CRP 
levels greater than 10 mg/L were also exclusionary for the present analyses.  Overall, 230 
subjects were excluded due to elevated inflammatory markers or absence of an identifiable 
census tract (e.g., an address coded by PO number), resulting in a final sample of 851 individuals 
for all primary (i.e. non-genetic) analyses.  This sample included 424 men and 427 women and 
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had a mean age of 44.9 years (SD = 6.5). European-Americans comprised 77 percent of study 
participants; the remaining 23 percent were African-American.  When compared with AHAB 
subjects excluded from analysis due to elevated inflammatory measurements or an unidentifiable 
Census tract, study participants did not differ in age or distribution of sex and ethnicity, personal 
socioeconomic indicators (educational attainment, income) or community characteristics 
(described below). Subjects excluded from analyses due to elevated inflammatory markers also 
did not differ from those subjects included in the genetic analyses on distribution of genotypes. 
Informed consent was acquired in compliance with guidelines of the University of Pittsburgh 
Institutional Review Board.   
 
2.1.1 Procedure. 
Prior to arrival at the laboratory, participants were asked to fast and abstain from exercise for 12 
hours, to abstain from alcohol for 24 hours and to abstain from nicotine for 1 hour. At the 
laboratory, a nurse then completed a medical history interview, height and weight measurements, 
and drew a 40 cc blood sample which was stored at -800C (see IL-6 measures).  
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2.2 MEASURES 
2.2.1 Socioeconomic Status 
2.2.1.1 Individual Socioeconomic Status 
Participant income and education were assessed as individual-level indices of SES.  Subjects 
were well-educated on average, with a mean of 15.3 (SD=2.8) years of schooling.  Levels of 
educational attainment nonetheless varied appreciably among study participants, with 5% 
lacking a high school diploma, 19% having completed high school or technical training only, 
24% with some college, 34% with a Bachelors degree, 15% with Masters degree, and 4% with 
an MD or PhD.   Annual (pre-tax) family income also varied substantially across participants, 
averaging <$25,000 in 22.6% of subjects, $25,000-49,999 in 27.3%, $50,000-$79,999 in 28.4%, 
and >$80,000 in 21.6% of participants. An index of individual-level SES was calculated by 
standardizing the distributions of educational attainment and family income across subjects, 
averaging the resulting Z-scores for each individual, and re-standardizing the resulting 
distribution (M=0, SD = 1; range: -2.41-1.99).  For four subjects lacking income data, individual 
SES was determined from educational attainment alone.  
2.2.1.2 Community Socioeconomic Status 
Participant’s home addresses were used to identify their Census Tracts of residence, based on the 
2000 US Census (http://www.census.gov/main/www/cen2000.html). Census tracts are 
geographical areas established to reflect a relatively homogeneous group of approximately 4000 
people (range 2500-8000) and 1500 housing units (range 1,000-3,000). For the 285 identified 
tracts, we extracted five Census variables: (1) median household income, (2) percentage of 
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individuals in the work force who were unemployed, (3) proportion of households below the 
federally designated poverty level; (4) percentage of households that were headed by a single 
woman with one or more children under the age of 18; and (5) percentage of persons over 25 
years of age who had completed a college education (Bachelor’s degree).  Distributions of all but 
the last variable were normalized by logarithmic transformation to reduce skew.  Following 
Manuck et al (2005) and Petersen et al (2006), an index of community SES was calculated as the 
average of the standardized scores of the five Census-derived variables, with signs adjusted so 
that higher values of each variable reflected more advantaged communities.  As with individual 
SES, this continuous index of community SES was then re-standardized (M=0, SD=1; range: –
3.07 to 2.21).  Illustrating the variability in community SES present in the sample, median values 
of the five extracted Census variables for upper and lower quartiles of the distribution of 
community SES were: $22,231 and $60,168 in median household income, 11.6% and 2.5% 
unemployment, 25.0% and 3.5% of households in poverty, 13.8% and 2.9% of households 
headed by a single mother, and 10.5% and 47.5% of adults over 25 having a college education. 
Across subjects, community SES correlated significantly with individual SES (r849 = 
0.539, p < 0.00001), as well as with its two components, educational attainment (r849 = .408, p < 
0.001) and current annual income (r845 = .485, p < 0.001), indicating that participants with 
lower incomes and less education tended also to live in less advantaged communities. 
Nevertheless, variability in the economic and material circumstances of the Census tracts 
represented here could be accounted for only partially by overlapping variation in individual 
SES. 
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2.2.2 Inflammation 
2.2.2.1 Interleukin-6 
IL-6 levels were determined using a high sensitivity quantitative sandwich enzyme 
immunoassay kit (R & D Systems) according to manufacturer’s directions. The assay standard 
range is from 0.156 to 10 pg/mL. IL-6 levels were extrapolated from a standard curve with linear 
regression from a log-linear curve. All samples were run in duplicate and the average coefficient 
of variation (CV) between samples was 5%. Reciprocal transformation was applied to normalize 
raw score distributions of the IL-6 values.  
2.2.2.2 C-Reactive Protein 
CRP was measured using the BNII nephelometer from Dade Behring utilizing a particle 
enhanced immunonephelometric assay. In this procedure, polystyrene particles are coated with 
monoclonal antibodies to CRP, which, in the presence of antigen agglutinate cause an increase in 
the intensity of scattered light. The increase in scattered light is proportional to the amount of 
CRP in the sample. The assay range is 0.175-1100 mg/L. Intra-assay CVs range from 2.3-4.4% 
and inter-assay CVs range from 2.1– 5.7%. Final CRP values were normalized by reciprocal 
transformation.  
2.2.3 Genotyping 
Genomic DNA will be isolated from EDTA anticoagulated whole blood using the 
Puregene kit (Gentra Systems,Minneapolis, MN). The IL6 (-174) polymorphism will be 
genotyped by the 5'-nuclease assay (TaqMan).  Amplification will use the primers F5' 
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GACGACCTAAGCTGCATTTTC-3' and R5' GGGCTGATTGGAAACCTTATTAAGATTG-
3', and detection oligonucleotides VIC5'-CCTTTAGCATCGCAAGAC-3' and FAM-5'-
CTTTAGCATGGAAGAC-3' (Livak, 1999). The genetic analyses conducted in this paper were a 
subsample (n=811) of both the group used for the initial socioeconomic analyses (n=851) and the 
larger AHAB dataset (n=1379). Use of this subsample was necessary because 40 of the 851 
subjects for whom we had intact address of residence and inflammatory data did not have 
genotype data.  With respect to Caucasians, genotyping in the larger AHAB sample consisted of 
1167 participants, and genotyping was successful on 1045 people. Of note, distribution of 
genotypes in this larger sample (n=1045) conformed with Hardy-Weinberg equilibrium (X21 = 
4.01, ns), as did the subgroup we excluded based on lack of address or inflammatory data (X21 
=.15, ns). The distribution of genotypes in the Caucasian subsample mildly deviated from Hardy-
Weinberg equilibrium (X12 = 4.17, p = .04). Genotypes in the African-American subsample also 
conformed with Hardy-Weinberg equilibrium (X12 = 0.73, p > .05). Please see Figure 1 for 
differences in frequency of -174 G>C genotypes by race (X22 = 110.99, p < .001).  
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Figure 1: Frequency of Genotype by Race. 
 
2.2.4 Additional Variables 
A number of variables were assessed that might confound any association between SES 
and IL-6. These variables include age, sex, race, body mass index (kg/m2), smoking status 
(current smoker versus ex/non-smoker), self- reported alcohol use (average number of alcoholic 
drinks/week), sleep volume (hours of sleep during last 7 nights = (average hours/week night x 5) 
+ (average hours/weekend night X 2), and exercise. Exercise was measured using the 
Paffenbarger Physical Activity Questionnaire, which is a widely used questionnaire that yields 
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an estimated kilocalorie expenditure over a 7-day period based on self-report of leisure time 
activity, walking, and stair climbing (Paffenbarger et al., 1978). The questionnaire has adequate 
retest reliability (Washburn, Smith, Goldfield, & McKinlay, 1991; Washburn, Adams, & Haile, 
1987; Ainsworth, Leon, Richardson, Jacobs & Paffenbarger, 1993), and is highly correlated with 
other measures of physical activity (summarized in Albanes et al, 1990). It is also highly 
correlated with maximal oxygen capacity (VO2 max) (r = .60, p < .05; Ainsworth et al., 1993), 
and demonstrates good predictive validity for coronary heart disease (e.g. Paffenbarger et al., 
1993).   
2.3 ANALYTIC STRATEGY 
Of note, due to the differences in the frequency distribution of -174 G>C genotypes in 
African-American and Caucasian subjects, all genetic analyses were performed separately in 
Caucasians and African-American groups (X22 =110.99, p < .001).  
Hypothesis 1: Hierarchical linear regression was employed to examine the association 
between SES (i.e. individual and community), entered on step 2, and IL-6 and CRP levels, 
after adjusting for age, gender, and race on step 1.  
Hypothesis 2: In order to determine the unique association of community and 
individual SES with IL-6 and CRP, hierarchical linear regression was used - with standard 
demographic characteristics (age, gender and race) entered on step 1 of the analyses, 
individual SES entered on step 2 of the analysis, and community SES entered on Step 3.  
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Hypothesis 3: To determine any mediating effect of health behaviors, the above analyses 
were repeated with the inclusion of standard demographic characteristics (age, gender and race) 
on step 1 of the analysis, health practices on step 2 (smoking, BMI, alcohol consumption, sleep 
and physical inactivity), individual SES on step 3, and community SES on step 4 of the analysis.  
Hypotheses 4 and 5:  Linear regression was again employed to determine whether there 
were mean differences in IL-6 or CRP levels based on genotype, and to determine whether there 
was an interaction between SES and genotype in predicting IL-6 and CRP. These analyses were 
run separately in Caucasians and African-Americans. In Caucasians, all variations of the -174 
G>C polymorphism were coded separately (i.e. GG, GC, and CC). A secondary model was run 
with two dichotomous genotypes (i.e. C allele present vs. GG homozygotes; G allele present vs. 
CC homozygotes) in Caucasians. Since the frequency of the GG genotype was extremely rare in 
this African-American sample (i.e. less than 1%), analyses were only conducted with the 
genotype dichotomized (i.e. CC homozygotes vs GG+GC).  Parallel analyses were employed 
using individual-level and community SES. SES and genotype variables were centered to reduce 
potential colinearity between the independent variables and their interaction product. Covariates 
were entered on step 1 of the model (age, sex), SES was entered on step 2, genotype on step 3, 
and the SES by genotype interaction term was entered on step 4. For any analyses where the 
genotype significantly predicted IL-6 or CRP, the regression was repeated with the inclusion of 
health behaviors on step 1 (smoking, BMI, alcohol consumption, sleep and physical inactivity).  
 33 
2.4 POWER ANALYSES 
Power calculations were conducted using the Sample Power program in SPSS.  With an 
alpha-level of .05, the power to detect an SES effect accounting for 1% of the variance in IL-6 
levels (after accounting for age, sex, and race) was 0.84 in the full sample (n=851). The power to 
detect a main effect for the  -174 G>C polymorphism accounting for 1% of the variance, after 
adjusting for age, sex, and socioeconomic status, was 0.72 in whites (n=624) and 0.29 in blacks 
(n=197). The power for detecting an SES by genotype  interaction effect accounting for 2% of 
the variance,  after adjusting for age, sex, socioeconomic status, and genotype, was also 0.72 in 
whites, and 0.29 in blacks.  
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3.0  RESULTS 
3.1 SOCIOECONOMIC STATUS AND INFLAMMATORY MARKERS 
Hypotheses 1-3, investigating socioeconomic and behavioral correlates of inflammation, 
were tested using the 851 subjects for whom we had data on all measures of SES, covariates, and 
inflammatory markers. Bivariate correlations describing the associations of these subject 
characteristics with community SES and with IL-6 and CRP levels are presented in Table 1. For 
convenience, the signs of correlations involving reciprocally transformed measurements of IL-6 
and CRP are reversed (as in all subsequent test statistics), so that positive (and negative) 
coefficients are interpreted as such. Consistent with prior literature, higher levels of IL-6 were 
associated with African American race, higher BMI, current smoking, consumption of 14 or 
more alcoholic drinks/week, fewer hours of sleep/week and less physical activity. Male gender 
also predicted higher levels of IL-6. Similarly, higher CRP was associated with African-
American race, higher BMI, and less physical activity. Neither CRP nor IL-6 covaried with age, 
nor was CRP associated with sex, smoking status, alcohol use, or sleep duration. Community and 
individual SES were similarly associated with covariates, with higher SES (predictably) 
associated with white race, non-smoking status, older age, lower BMI, more physical activity, 
and more sleep in the previous week.  
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Table 1: Bivariate correlations with covariates, CRP, IL-6, Community and Individual 
SES. 
 N=851 
M (SD) 
CRP  IL-6  Comm SES 
 
Indiv SES 
Age, yrs 44.9 (6.5) -.035 .036 .113** .132** 
Gender, % ma 49.8% .057 -.080* -.004 .018 
Race, % AA 23% .094** .162** -.547** -.434** 
BMI, kg/m2 27.5 (5.7) .484** .306** -.146** -.122** 
Smoking,%current 18% .055 .206** -.278** -.333** 
Exercise 2407.1 
(1836.1) 
-.120** -.149** .151** .186** 
Alcohol, >14/wk 7% -.025 .072* -.031 -.058 
Sleep, hrs/wk 47.7 (7.5) -.046 -.093** .094** .068* 
SES: 
    Indiv 
 
0 (1) 
 
-.079* 
-.170** .539**  
   Community 0 (1) -.142** -.201**   
 
**P<.01, *P<.05, +P<.10 
Individual and Community SES indices are expressed as z-scores (M = 0). Race coded 0 = White, 1 = Black. BMI = 
body mass index; Smoking Status (0=not current, 1=current); correlations were conducted on the transformed CRP 
and IL-6 variables, but signs were reversed in the table for ease of interpretation;  †rpb = point biserial correlation.  
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3.1.1 Hypotheses 1: Does inflammation (i.e. IL-6 and CRP) covary with individual or 
community socioeconomic status? 
As also shown in Table 1, circulating levels of IL-6 and CRP covaried inversely with 
both individual and community SES.  Results of regression analyses examining the association 
between SES and inflammatory markers after adjusting for age, sex, and race can be found in 
Table 2. When entered on the first step of the model, age, sex and race accounted for 3.7% of the 
variance in IL-6 concentration (F3, 847 = 10.91, p = .000), and 1.2% of the variance in CRP (F3, 847 
= 3.55, p = .014). Males had higher concentrations of IL-6, and African-Americans had higher 
concentrations of both IL-6 and CRP. Individual SES, entered on step 2 of the models, continued 
to predict IL-6 (F1, 846 = 11.26, B=-.126,p < .001), but not CRP (F1, 846 = 1.55, B= -.047, p = 
.214), whereas in similarly adjusted regression models, community SES predicted both IL-6 (F1, 
846 = 16.55, B= -.163, p <.001) and CRP (F1, 846= 9.99, B= -.129, p = .002).  Regarding the latter 
associations, then, study participants living in less advantaged Census tracts showed higher 
plasma concentrations of the two inflammatory markers than did residents of more affluent 
neighborhoods. To examine the possibility that these community associations might exist only in 
analyses performed on data transformed to satisfy parametric assumptions of normality, box-
plots of untransformed IL-6 and CRP measurements are displayed in Figure 2.  The values 
depicted here are partitioned by quartiles of the distribution of participants’ community ‘scores’, 
which are the standardized residuals created by regressing age, sex and race on participants' 
community SES values.  For both inflammatory markers, median values among subjects 
comprising the lowest quartile of community SES were greater than those of the highest quartile, 
and non-parametric statistic (Mann-Whitney U) corroborated these end-quartile differences 
(Mann-Whitney U) (IL-6: Z = 3.9, p < 0.0001; CRP: Z = 3.3, p < 0.0009).  The Spearman rank-
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order correlation of community SES (adjusted for age, sex, and race) with untransformed 
inflammatory markers was likewise significant, across all subjects, for both IL-6 (rho = -0.139, p 
< 0.0001) and CRP (rho = -0.110, p < 0.0015) (For comparison, Pearson correlations between 
the adjusted community variable and reciprocally transformed IL-6 and CRP values (signs 
reversed) were virtually identical [IL-6: r = -0.136, p < 0.0001; CRP: r = -0.107, p < 0.002]). 
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 Table 2: Hierarchical regression analyses assessing the relationship between 
individual/community SES and inflammatory markers after adjusting for age, sex, and race 
(Hypothesis 1). 
Linear 
Regression 
∆R2 B P 
DV: IL-6    
Step 1:  .037  .000 
Age  .055 .107 
Gender  -.091 .007 
Race  .172 .000 
Step 2:    
Individual SES .013 -.126 .001 
    
DV: CRP    
Step 1: .012   
Age  -.029 .393 
Gender  .054 .117 
Race  .089 .010 
Step 2: .002   
Individual SES  -.047 .214 
    
DV: IL-6    
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Step 1:  .037  .000 
Age  .055 .107 
Gender  -.091 .007 
Race  .172 .000 
Step 2:    
Community SES .018 -.163 .000 
    
DV: CRP    
Step 1:  .012  .014 
Age  -.029 .393 
Gender  .054 .117 
Race  .089 .010 
Step 2: .012   
Community SES  -.129 .002 
*Dependent variables are the reciprocal transformations of CRP and IL-6, but signs have been 
reversed for ease of interpretation.  
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 Figure 2: Distribution of the untransformed values of IL-6 and CRP depicted for   
 quartiles of age, sex, and race-adjusted Community SES.  IQR = inter-quartile   
 range. 
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3.1.2 Hypothesis 2: Does community SES predict inflammatory markers independently of 
individual SES? 
In additional regression analyses, community SES was entered as a predictor on step 3, 
after demographic covariates and individual SES, and again, the area-level socioeconomic index 
explained significant variability in both IL-6 (B=-.130, p =.003) and CRP (B=-.129, p=.004). 
Results are displayed in table 3. Thus, the association of community SES with these two 
inflammatory markers was not attributable to correlated variation in personal socioeconomic 
indicators. 
 42 
 Table 3: Hierarchical regression analyses assessing the relationship between 
community SES and inflammatory markers after adjusting for age, sex, race, and 
individual SES (Hypothesis 2). 
Linear 
Regression 
∆R2 B P 
DV: IL-6    
Step 1:  .037  .000 
Age  .055 .107 
Gender  -.091 .007 
Race  .172 .000 
Step 2: .013   
Individual SES  -.126 .001 
Step 3: .010   
Community SES  -.130 .003 
 
DV: CRP    
Step 1: .012   
Age  -.029 .393 
Gender  .054 .117 
Race  .089 .010 
Step 2: .002   
Individual SES  -.047 .214 
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Step 3: .010   
Community SES  -.129 .004 
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3.1.3 Hypothesis 3: Is SES (both individual and community) associated with IL-6 and 
CRP independently of concomitant variation in health behaviors?  
Finally, analyses were conducted to determine whether health practices could account for 
relationships of either individual or community SES with markers of inflammation, and results 
can be found in Table 4. As expected, after controlling for age, sex and race, higher BMI 
(B=.285, p = .000), current smoking (B=.172, p = .000), and less physical activity (B=-.074, p = 
.024) were associated with higher IL-6 levels. Similarly, higher BMI (B = .491, p = .000) and 
current smoking status (B = .073, p = .023) predicted higher CRP levels independently of 
demographic characteristics. Interestingly, individual SES was no longer associated with IL-6 
when entered into regression after demographic covariates and both BMI and health behaviors 
(B=-.049, p = .186). Community SES, on the other hand, remained a significant, independent 
predictor of IL-6 (B = -.098, p = .011) and CRP (B = -.072, p=.049), with age, sex, race, BMI, 
smoking status, and physical activity in the model. And when entered after demographic 
covariates, BMI and health behaviors, and individual SES in a final regression analysis, 
community SES continued to predict both IL-6 and CRP (B=-.091, p = .028 and B = -.086, p = 
.027). 
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Table 4: Hierarchical regression analyses assessing the relationship between SES and 
inflammatory markers after adjusting for health behaviors.  
Linear 
Regression 
∆R2 B P 
DV: IL-6    
Step 1:  .037   
Age  .055 .107 
Gender  -.091 .007 
Race  .172 .000 
Step 2: .121   
Smoking  .172 .000 
BMI  .285 .000 
Sleep  -.049 .128 
Physical Activity  -.074 .024 
Alcohol  .061 .059 
Step 3: .002   
Individual SES  -.049 .186 
Step 4: .005   
Community SES  -.091 .028 
    
DV: CRP    
Step 1:  .012   
Age  -.029 .393 
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Gender  .054 .117 
Race  .089 .010 
Step 2: .238   
Smoking  .073 .023 
BMI  .491 .000 
Sleep  -.020 .505 
Physical Activity  -.024 .436 
Alcohol  .011 .708 
Step 3: .000   
Individual SES  .009 .802 
Step 4: .005   
Community SES  -.086 .027 
*Dependent variables are the reciprocal transformations of CRP and IL-6, but signs have been 
reversed for ease of interpretation.  
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 3.1.4 Stratified Analyses 
Tests of potential interactions between community SES  and race were not significant, 
suggesting that the foregoing associations were not qualified by participant race (IL-6: B = -.070, 
p = .199; CRP: B=.006, p = .910). Nonetheless, African American participants lived 
disproportionately in poorer Census tracts than whites, as reflected in our composite community 
index (African Americans: M = -1.00 [SD = 0.95]; Whites: M = 0.30 [SD = 0.80]; t849 = 19.1, p 
< 0.0001).  Because inequalities among communities were thus partly confounded by race, we 
next asked whether community SES predicted inflammatory markers in analyses conducted 
separately on Whites (n = 654) and African Americans (n = 197).  The bivariate correlation of 
community SES with IL-6 in Whites was -0.15 (p < 0.0001) and in Black participants, -0.08 
(n.s.); corresponding correlations for CRP were -0.11 (p < 0.007) in Whites and -0.12 (p < 0.10) 
in Blacks.  Linear regressions adjusting for age and sex further corroborated these associations 
(White, IL-6: B = -0.16, p < 0.001; CRP: B = -0.11, p < 0.01; African American, IL-6: B = -0.09, 
n.s.; CRP: B = -0.13, p < 0.08). Please see tables 5 & 6 for results from stratified regression 
analyses.  When both demographic factors and individual SES were entered first, effects of 
community SES were weakened, but continued to predict IL-6 (B = -0.13, p < 0.002) and CRP 
(B = -0.09, p < 0.04) levels in Whites.  Interestingly, among African Americans, community SES 
accounted for significant variance in CRP after entering age, sex, and individual SES, while the 
community association with IL-6 (B = 0.03) remained non-significant.  Among White 
participants, community SES remained a significant predictor of IL-6 after age, sex, BMI and 
health behaviors were entered (B = - 0.11, p = 0.005), as well as in the fully adjusted model 
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including both these covariates and individual SES (B = -0.10, p < 0.015).  However, the 
community variable did not account for significant variation in CRP in parallel analyses 
adjusting for other risk factors among Whites, and predicted neither IL-6 nor CRP levels in 
similarly adjusted models among Blacks. 
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Table 5: Hierarchical regression analyses assessing the relationship between community 
SES and inflammatory markers after adjusting for age, sex, race, health behaviors, and 
individual SES in whites alone. (Hypothesis 3)   
Linear 
Regression 
∆R2 B P 
DV: IL-6    
Step 1:  .016   
Age  .048 .222 
Gender  -.118 .003 
    
Step 2: .109   
Smoking  .135 .000 
BMI  .275 .000 
Sleep  -.043 .255 
Physical Activity  -.077 .042 
Alcohol  .041 .283 
Step 3: .003   
Individual SES  -.057 .135 
Step 4: .008   
Community SES  -.098 .015 
    
DV: CRP    
Step 1:  .001   
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Age  -.028 .481 
Gender  .027 .490 
Step 2: .292   
Smoking  .029 .402 
BMI  .540 .000 
Sleep  -.026 .440 
Physical Activity  -.024 .489 
Alcohol  -.011 .745 
Step 3: .000   
Individual SES  -.019 .572 
Step 4: .002   
Community SES  -.045 .211 
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Table 6: Hierarchical regression analyses assessing the relationship between community 
SES and inflammatory markers after adjusting for age, sex, race, and health behaviors, 
and individual SES in African-Americans alone. (Hypothesis 3) 
Linear 
Regression 
∆R2 B P 
DV: IL-6    
Step 1:  .007   
Age  .083 .246 
Gender  -.006 .937 
Step 2: .184   
Smoking  .269 .000 
BMI  .331 .000 
Sleep  -.079 .240 
Physical Activity  -.047 .501 
Alcohol  .152 .024 
Step 3: .000   
Individual SES  -.011 .882 
Step 4: .000   
Community SES  -.012 .872 
    
DV: CRP    
Step 1:  .019   
Age  -.032 .650 
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Gender  .135 .059 
Step 2: .160   
Smoking  .163 .019 
BMI  .375 .000 
Sleep  .006 .935 
Physical Activity  -.004 .951 
Alcohol  .102 .132 
Step 3: .009   
Individual SES  .108 .142 
Step 4: .014   
Community SES  -.133 .069 
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3.1.5 Summary Socioeconomic Status and Inflammatory Markers 
In sum, hypotheses one, two, and three were largely supported, and our analyses show a 
significant relationship between socioeconomic variation at both the individual and community 
level in the prediction of inflammatory markers. IL-6 and CRP covaried with both individual and 
community SES in univariate models, and individual SES continued to predict IL-6 after 
adjustment for age, sex, and race. The association between community SES and both IL-6 and 
CRP persisted after adjustment for age, sex, race, health behaviors (i.e. alcohol, smoking, sleep, 
BMI, physical activity), and individual SES.  
3.2 GENETIC INFLUENCES ON INFLAMMATORY MARKERS 
3.2.1 Caucasian Subsample 
As noted in the introduction, the multiple determinants of circulating IL-6 and CRP levels 
include cytokine-related genetic variation, and quantitative genetic studies estimate 17-24% of 
variation in IL-6 levels to be attributable to heritable factors. The objective of hypothesis four 
was to determine whether a previously identified functional single nucleotide polymorphism in 
the promoter region of the IL-6 gene (i.e. 174 G>C) was associated with both IL-6 and CRP in 
this middle-aged, relatively healthy sample. Hypothesis five examined whether community or 
individual SES interacted with the 174 G>C polymorphism in the prediction of IL-6 or CRP. Of 
the 851 participants used in the initial analyses (i.e. hypotheses 1-3), forty participants did not 
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have valid genotype data, leaving a final sample of 811 subjects for genetic analyses (n=624 
Caucasian, n=187 African-American).  
3.2.1.1  Preliminary Analyses 
Genetic analyses in the Caucasian subsample used all three genotypes (i.e. GG, GC, CC) 
and were repeated with the genotype dichotomized two ways (i.e. GG vs GC+CC and GG+GC 
vs CC). To determine whether relevant participant characteristics (i.e. age, sex, BMI, smoking 
status, alcohol consumption, physical activity, individual and community SES) varied by 
genotype, we first subjected these variables to analysis of variance, Chi-square, and t-test. 
Results of these univariate analyses can be found in Table 7.  
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 Table 7: Univariate participant characteristics by genotype in white subsample (n=624).  
Participant 
Characteristics 
(n=624) 
Genotype  
(CC,CG,GG) 
Genotype 
(CC+CG,GG)
Genotype  
(CC,CG+GG)
Age F2, 624 = 0.72 t622 = 1.18 t622 = .64 
Sex Cramer’s V2 
= 0.04 
X12 = .008 X12 = .81 
BMI F2, 624 = 1.86 t622 = 0.73 t622 = -1.39 
Alcohol X22=3.95, eta 
= .06  
X12 = 3.94* X12 = .45 
Sleep F2,624 = 3.47* t622 = -2.42 t622 = .07 
Smoking  X22 = 1.36, 
eta = .03 
X12 = 0.03 X12 = 1.29 
Exercise F2,624 = 0.170 t622 = -0.33 t622 = .33 
1/IL-6 F2, 624 = 1.23 t622 = 0.11 t622 = -1.42 
1/CRP F2,624 = 2.67^ t622 = 2.0* t622 = -.34 
Ind SES F2,624=4.71** t622 = -1.11 t622 = 2.25* 
Com SES F2, 624 = 1.76 t622 = 1.84^ t622 = 1.01 
 
^ = p < .10; * = p < .05; **p < .01. Alcohol, 0-13.99 drinks/wk, > 14 drnks/wk; smoking, 
current vs non-smoker.  
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The 174 G>C genotype (i.e. coded CC, CG, GG) was associated with sleep and 
individual SES, but not with the other variables of interest (sleep: F2, 624 = 3.47, p < .05; CC M = 
48.12, SD = 6.5; CG M = 47.48, SD = 7.6; GG M =49.56, SD = 6.7; individual SES: F2, 624 = 
4.71, p < .01; CC M = .114, SD = 1.01; CG M = -.137, SD = 1.02; GG M =.095, SD = .875). 
Pairwise comparisons showed CG heterozygotes to sleep less than GG homozygotes (Mean 
difference: -2.08, p < 01; please see table 8). Individual SES was also significantly lower among 
CG heterozygotes, relative to both CC and GG homozygotes (M diff CC: -.25, p < .01, M diff 
GG: -.23, p < .05 – please see table 9).  
 57 
    Table 8: Pairwise Comparisons of Sleep by Genotype 
 (I) 
1=C/C, 2=C/G, 
3=G/G 
(J) 
1=C/C, 2=C/G, 
3=G/G 
Mean Difference (I-
J) 
Std. 
Error 
Sig.
(a) 
          
C/C C/G .64 .62 .30 
  G/G -1.44 .81 .08 
C/G C/C -.64 .62 .30 
  G/G -2.08(*) .79 .01 
G/G C/C 1.44 .81 .08 
  C/G 2.08(*) .79 .01 
Based on estimated marginal means 
*  The mean difference is significant at the .05 level. 
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Table 9: Pairwise Comparisons of Individual SES by Genotype 
 (I) 
1=C/C, 2=C/G, 
3=G/G 
(J) 
1=C/C, 2=C/G, 
3=G/G 
Mean Difference 
(I-J) 
Std. 
Error 
Sig.
(a) 
          
C/C C/G .252(*) .088 .004 
  G/G .019 .114 .865 
C/G C/C -.252(*) .088 .004 
  G/G -.232(*) .111 .037 
G/G C/C -.019 .114 .865 
  C/G .232(*) .111 .037 
Based on estimated marginal means 
*  The mean difference is significant at the .05 level. 
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When the genotype was dichotomized (i.e. 1 = CG+CC, 2= GG), GG homozygotes 
consumed more alcohol (X12 = 3.94, p < .05) and had higher community SES (t622 = 1.84, p < 
.05), than subjects carrying any C allele. This dichotomized genotype was not associated with 
age, sex, smoking status, BMI, or individual SES (ps >.10).  Dichotomized another way (i.e. CC 
vs CG+GG), subjects carrying any G allele had higher individual SES than CC homozygotes 
(t622 = 2.25, p < .05).  
 These preliminary analyses also show mean circulating levels of reciprocally 
transformed IL-6 among Caucasian GG, GC and CC participants to be 0.44 (SD =.17 , 
untransformed M = 1.90 pg/mL), 0.43 (SD=.16, M = 1.93 pg/mL), and 0.45 pg/mL (SD = .15, 
M=1.64 pg/mL), and reciprocally transformed CRP values to be 0.55 (SD=.21, untransformed M 
= 1.39 mg/L), 0.50 (SD= .22, M = 1.69 mg/L), 0.52 mg/L (SD = 0.21, M = 1.56 mg/L).  Subjects 
of the three IL-6 174 G>C genotypes did not differ in circulating IL-6 (F2, 624 = 1.23, p = .29), 
and showed a trend for significant differences in CRP (CRP: F2, 624 2.67, p = .07). Pairwise 
comparisons show this trend was attributable to a slightly higher CRP concentration in CG vs 
GG genotypes (please see table 10). Similar analyses on the dichotomized polymorphism (i.e. 
CC+CG vs GG) showed GG homozygotes to have lower mean CRP concentrations than subjects 
with any C allele (t622 = 2.00, p < .05; untransformed M CC+CG = 1.63 mg/L, M GG = 1.39 
mg/L) but no differences in mean IL-6 levels were evident by genotype (t622 = -0.11, p > .10). 
Finally, when CC homozygotes were contrasted with subjects carrying any G allele, no 
differences were found in IL-6 or CRP concentrations (t622 = -1.42, p > .10; t622 = -.34, p > .10, 
respectively). In sum, examining IL-6 and CRP by the three possible genotypes of the 
polymorphism revealed no differences in circulating concentrations. Dichotomizing the 
polymorphism showed GG homozygotes to have lower CRP relative to subjects carrying any C 
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allele. The final dichotomization of genotype, contrasting CC homozygotes with subjects 
carrying any G allele, showed no differences in IL-6 or CRP concentrations.  
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Table 10: Pairwise Comparisons of Reciprocally Transformed CRP by Genotype 
 
 (I) 
1=C/C, 2=C/G, 
3=G/G 
(J) 
1=C/C, 2=C/G, 
3=G/G 
Mean 
Difference (I-J) 
Std. 
Error 
Sig.
(a) 
          
C/C C/G .022 .019 .247 
  G/G -.033 .025 .181 
C/G C/C -.022 .019 .247 
  G/G -.055(*) .024 .023 
G/G C/C .033 .025 .181 
  C/G .055(*) .024 .023 
Based on estimated marginal means 
*  The mean difference is significant at the .05 level. 
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3.2.2 Hypotheses 4 and 5: Is the G allele associated with higher circulating levels of IL-6 
and CRP? And, do SES (i.e. either individual or community) and genotype interact in the 
prediction of IL-6 or CRP? 
Regression Analyses 
Several parallel hierarchical regression models were executed to examine the association 
between inflammatory markers  (i.e. IL-6 or CRP) and SES (i.e. either individual or community), 
genotype, and the genotype by SES interaction term. On step 1 of these analyses, age and sex 
were entered. Step 2 contained either individual or community SES, and genotype was entered 
on step 3 (either CC, CG and GG; CC+CG vs GG; or CC vs CG+GG), while the final step 
included the genotype by SES interaction term. Results of these models are displayed in tables 
11-15. Because age, sex, and either individual or community SES associations with the 
dependent variable (i.e. IL-6 or CRP) do not vary among models, these results are presented only 
with the first regression model for each dependent variable.  
3.2.2.1 Individual SES, Genotype, and IL-6 
Results of the hierarchical regression for IL-6, where IL-6 174 G>C is entered by its three 
genotypes, are presented in Table 11. When entered on the first step of the analysis, female 
gender predicted higher IL-6 (B = -.118, p < .01), while age was not associated with IL-6. Higher 
individual SES, entered on step 2, predicted lower IL-6 (B = -.11, p < .01), as it had done in 
analyses of the entire sample presented earlier. Entered on the two subsequent steps, neither the 
main effect of genotype (i.e. CC, CG, GG) nor the interaction of genotype by individual SES 
accounted for significant variation in IL-6 (p’s > .10). The pattern of results with the genotype 
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dichotomized both ways was identical, with no additional variance in IL-6 accounted for by 
either genotype or the genotype by individual SES interaction term (ps > .10). 
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Table 11: Hierarchical regression analyses assessing the relationship between 
genotype and IL-6 after adjusting for age, sex, individual SES and individual SES x 
genotype in whites alone.  (Hypotheses 4 and 5). 
Linear 
Regression 
∆R2 B P 
DV: IL-6    
Step 1:  .016   
Age  .052 .194 
Gender  -.118 .003 
Step 2: .012   
Individual SES  -.111 .005 
Step 3: .001   
Genotype (GG, 
GC, CC) 
 .038 .341 
Step 4: .000   
Indiv SES x 
Genotype 
 -.006 .887 
    
DV: IL-6    
Step 3:  .000   
Genotype 
(GC+CC, GG) 
 .004 .921 
Step 4: .000   
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Individual SES x 
Genotype  
 .001 .980 
    
Step 3: .003   
Genotype (CC vs 
GG+GC) 
 .053 .181 
Step 4: .000   
Indiv SES x 
Genotype 
 -.006 .884 
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 3.2.2.2 Individual SES, Genotype, and CRP 
Results of parallel regression models with CRP can be found in Table 12. Step 1 of the analysis 
shows age and sex were not associated with CRP in this Caucasian subsample, but higher 
individual SES was marginally associated with less CRP (B=-.07, p = .08) when entered on step 
2 of the model. Neither the main effect of genotype (i.e. CC, CG, GG), entered on step 3, nor the 
individual SES by genotype interaction terms, entered on the final step, were significant 
predictors (ps > .10). A parallel model with the dichotomized genotype shows that when GG 
homozygotes were contrasted with subjects carrying any C allele in step 3 of the model, GG 
homozygotes had lower CRP than subjects with CC+CG genotypes (B = -.08, p = .05), but the 
interaction of genotype by individual SES was not associated with CRP (p>.10). Finally, a third 
model showed no association between CRP and genotype when contrasting CC homozygotes 
with the combined GC and GG genotypes (ps > .10).  
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Table 12: Hierarchical regression analyses assessing the relationship between 
genotype and CRP after adjusting for age, sex, individual SES and individual SES x 
genotype in whites alone.  (Hypotheses 4 and 5).  
Linear 
Regression 
∆R2 B P 
DV:CRP    
Step 1:  .001   
Age  -.020 .626 
Gender  .027 .497 
Step 2: .005   
Individual SES  -.070 .083 
Step 3: .001   
Genotype (GG, 
GC, CC) 
 -.037 .355 
Step 4: .000   
Indiv SES x 
Genotype 
 -.015 .712 
    
DV: CRP    
Step 3:  .006   
Genotype 
(GC+CC, GG) 
 -.078 .052 
Step 4: .000   
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Individual SES x 
Genotype  
 .014 .722 
DV: CRP    
Step 3: .000   
Genotype (CC vs 
GG+GC) 
 .006 .874 
Step 4: .001   
Indiv SES x 
Genotype 
 -.031 .435 
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3.2.2.3 Summary of Individual SES, Gene, and Inflammatory Markers 
In sum, consistent with analyses presented earlier, subjects of lower individual SES had higher 
concentrations of IL-6, but neither main effect of genotype nor the interaction of genotype by 
individual SES were associated with IL-6. With regard to CRP, higher individual SES 
marginally predicted lower CRP, and GG homozygotes had lower circulating CRP relative to 
subjects carrying any C allele (i.e. CG + CC), but genotype did not interact with individual SES 
in predicting CRP.   
3.2.2.4  Community SES, Genotype, and IL-6 
In an additional set of regression analyses, we next considered a main effect of genotype after 
adjusting for age, sex, and community SES, and finally examined the possibility of a community 
SES by genotype interaction in predicting IL-6 (see table 13). After adjusting for age and sex, 
hierarchical regression analyses showed participants with higher community SES, entered on 
step 2, to have lower circulating IL-6 (B=-.16, p < .01), consistent with analyses presented 
earlier. There was neither a main effect of genotype (step 3) nor an interaction of genotype by 
community SES (step 4) in predicting IL-6, irrespective of the coding of the genotype (all ps > 
.10).  
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 Table 13: Hierarchical regression analyses assessing the relationship between 
genotype and community SES x genotype and IL-6 after adjusting for age, sex, and 
community SES in whites alone. (Hypotheses 4 and 5).  
Linear 
Regression 
∆R2 B P 
DV: IL-6    
Step 1:  .016   
Age  .052 .194 
Gender  -.118 .003 
Step 2: .024   
Community  SES  -.157 .000 
Step 3: .001   
Genotype (GG, 
GC, CC) 
 .031 .428 
Step 4: .001   
Comm SES x 
Genotype 
 -.032 .423 
    
DV: IL-6    
Step 3:  .000   
Genotype 
(GC+CC, GG) 
 -.013 .747 
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Step 4: .001   
Comm SES x 
Genotype  
 -.027 .499 
DV: IL-6    
Step 3: .003   
Genotype (CC vs 
GG+GC) 
 .056 .153 
Step 4: .001   
Comm SES x 
Genotype 
 -.031 .429 
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3.2.2.5 Community SES, Genotype, and CRP 
In this Caucasian subsample, lower community SES predicted higher CRP (B=-.111, p < 
.01) after adjusting for age and sex, as it had done in analyses reported earlier. Three separate 
regressions were run with genotype for the 174 G>C polymorphism coded differently (see table 
14), and only one main effect for genotype in the prediction of CRP was found. When the 
genotype was dichotomized (i.e. CC+CG vs GG), subjects carrying any C allele had higher CRP 
(B = -.09, p < .05) relative to GG homozygotes, but the genotype by community SES interaction 
was not significant (p>.10).  
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Table 14: Hierarchical regression analyses assessing the relationship between 
genotype and community SES x genotype with CRP after adjusting for age, sex, and 
community SES in whites alone. (Hypotheses 4 and 5).  
 
Linear 
Regression 
∆R2 B P 
DV: CRP    
Step 1:  .001   
Age  -.020 .626 
Gender  .027 .497 
Step 2: .012   
Community  SES  -.111 .006 
Step 3: .002   
Genotype (GG, 
GC, CC) 
 -.042 .292 
Step 4: .000   
Comm SES x 
Genotype 
 -.022 .590 
    
DV: CRP    
Step 3:  .008   
Genotype 
(GC+CC, GG) 
 -.089 .025 
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Step 4: .000   
Comm SES x 
Genotype  
 -.010 .811 
DV: CRP    
Step 3: .000   
Genotype (CC vs 
GG+GC) 
 .008 .841 
Step 4: .002   
Comm SES x 
Genotype 
 -.046 .250 
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3.2.2.6 Health Behaviors 
Additional analyses designed to explore whether health behaviors might affect the relationship 
between the dichotomized genotype (i.e. CC+CG vs GG) and CRP were conducted next. Results 
are displayed in table 15. On step 1 of the regressions, age, sex, sleep, BMI, smoking status (non 
vs. current), alcohol consumed per week (0-13.99 vs >14 drinks/week), and physical activity 
were entered. Step 2 included the relevant SES measure (either individual or community), with 
genotype entered on step 3, and the genotype by SES interaction term entered on step 4.  
Including these health behaviors eliminated the association between individual SES and CRP, 
and showed female gender (B = .12, p < .01) and higher BMI (B = .54, p < .01) to predict higher 
CRP. After including these health behaviors, the dichotomized genotype was marginally 
associated with CRP (B = - .06, p = .07). With regard to the community SES model, genotype 
remained a significant predictor of CRP (B = -.07, p = .05). To summarize, inclusion of health 
behaviors in parallel models with individual and community SES weakened, but did not 
eliminate, the association between genotype and CRP. Neither CRP nor IL-6 varied as a function 
of any genotype by SES interaction.   
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Table 15: Hierarchical linear regression analyses predicting CRP by genotype and SES 
(i.e. individual and community) after adjusting for age, sex, race, and health behaviors in 
whites alone. 
Linear 
Regression 
∆R2 B P 
DV: CRP    
Step 1:  .294   
Age  -.034 .320 
Gender  .124 .001 
Sleep  -.022 .536 
BMI  .541 .000 
Smoking Status  .033 .353 
Alcohol  -.015 .662 
Physical Activity  -.030 .390 
Step 2: .000   
Individual SES  -.018 .616 
Step 3: .004   
Genotype (GG vs 
GC+CC) 
 -.063 .065 
Step 4: .000   
Indiv x Genotype   .005 .889 
 
DV: CRP 
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Step 2: .002   
Community SES  -.050 .151 
Step 3: .005   
Genotype (GG vs 
GC+CC)  
 -.068 .046 
Step 4: .001   
Comm SES x 
Genotype 
 .034 .320 
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3.2.3 African-American Subsample 
Preliminary Subsample 
In the African-American subsample (n=187), the distribution of genotypes conformed with 
Hardy-Weinberg equilibrium (X12 = 0.73, p > .05). Due to the extremely low frequency of the 
GG genotype in African-Americans (n=3), GG homozygotes and GC heterozygotes are 
combined for analyses. Preliminary results showed baseline IL-6 and CRP levels did not vary by 
genotype (IL-6: t185 = -.62, p >.05; CRP: t185 = -.92, p > .05). Reciprocally transformed IL-6 
means among subjects carrying any G allele (i.e. GG/GC) and CC homozygotes were 0.39 (SD = 
.13, untransformed M = 1.98 pg/mL) and 0.37 pg/mL (SD = .15, M = 2.44pg/mL), respectively, 
and reciprocally transformed CRP values were 0.43 (SD = .23, untransformed M = 2.37 mg/L) 
and 0.47 mg/L (SD = .24, M = 2.05mg/L). As summarized in table 16, age, sex, alcohol 
consumption, smoking status, body mass index, exercise, sleep, individual and community SES 
did not vary by genotype (p’s > .05).  
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Table 16: Univariate participant characteristics by genotype in black subsample (n=187). 
  
Participant     
Characteristics 
Genotype  
(CC, CG+GG) 
Age t185 = .01 
Sex X12 = .06 
BMI t185 = .22 
Alcohol X12 = .08 
Sleep t185 = -.21 
Smoking X12 = 3.32 
Exercise t185 = .54 
1/IL-6 t185 = -.50 
1/CRP t185 = .92 
Individual SES t185 = -.24 
Comm SES t185 =-.10 
 
 ^ = p < .10; * = p < .05; **p < .01. Alcohol, 0-13.99 drinks/wk, > 14 drnks/wk; 
 smoking, current vs non-smoker.  
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 3.2.3.1 Hypotheses 4&5: Is the G allele associated with greater circulating IL-6 and CRP, 
and is there an interaction between genotype and SES in predicting inflammation? 
Parallel regression models examining the contribution of individual and community SES, alone 
and in interaction with 174G>C (1=CC, 2 = GG+CG), were also conducted.  These models, 
adjusting for age and sex in step 1, are summarized in tables 17-18. They showed no association 
between individual SES (step 2), genotype (step 3), or the interaction of individual SES and 
genotype (step 4) in predicting levels of circulating IL-6 or CRP.   Community SES, genotype, 
and the interaction of community SES and genotype also were not associated with IL-6 or CRP 
after adjusting for age and sex. In sum, analyses in the African-American subsample showed 
variation in inflammatory markers (i.e. IL-6 and CRP) was not accounted for by genotype in this 
study.  
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Table 17: Hierarchical regression analyses assessing the relationship between 
genotype and individual SES by genotype with inflammatory markers after adjusting for 
age and sex in blacks alone (Hypotheses 4 and 5).    
Linear 
Regression 
∆R2 B P 
DV:IL-6    
Step 1:  .010   
Age  .100 .173 
Gender  -.018 .810 
Step 2: .012   
Individual SES  -.111 .144 
Step 3: .001   
Genotype (CC,  
GG+CG) 
 -.035 .634 
Step 4: .000   
Indiv SES x 
Genotype 
 .006 .941 
    
DV: CRP    
Step 1:  .017   
Age  -.021 .246 
Gender  .128 .937 
Step 2: .000   
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Individual SES  .006 .937 
Step 3: .005   
Genotype (CC,  
GG+CG) 
 .070 .341 
Step 4: .004   
Indiv SES x 
Genotype 
 -.067 .363 
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Table 18: Hierarchical regression analyses assessing the relationship between 
genotype and the community SES by genotype interaction withinflammatory markers 
after adjusting for age and sex in blacks alone.  (Hypotheses 4 and 5).  
 
Linear 
Regression 
∆R2 B P 
DV:IL-6    
Step 1:  .010   
Age  .100 .173 
Gender  -.018 .810 
Step 2: .002   
Comm SES  -.048 .513 
Step 3: .001   
Genotype (CC,  
GG+CG) 
 -.037 .617 
Step 4: .000   
Comm SES x 
Genotype 
 .003 .970 
    
DV: CRP    
Step 1:  .017   
Age  -.021 .246 
Gender  .128 .937 
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Step 2: .015   
Comm SES  -.122 .095 
Step 3: .005   
Genotype (CC,  
GG+CG) 
 .071 .330 
Step 4: .006   
Comm SES x 
Genotype 
 -.077 .290 
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4.0  DISCUSSION 
Despite a well documented inverse association between individual level socioeconomic 
status and cardiovascular disease, and a more recent literature showing area-level measures of 
SES to be independently associated with cardiovascular morbidity and mortality, mechanisms 
explaining these associations are not fully understood. In the last decade, multiple lines of 
research have documented the pathogenic role of inflammation in the development of 
atherosclerotic cardiovascular disease. Subsequently, a limited literature has examined whether 
inflammation might covary with individual SES and mediate its association with atherosclerotic 
cardiovascular disease. Thus, hypotheses one to three of this study aimed to extend this literature 
and examine whether socioeconomic status, at the level of both the individual and the 
community, is associated with two markers of inflammation (i.e. IL-6 and CRP) that are 
frequently cited as predictive, and potentially pathogenic, in the development of atherosclerotic 
cardiovascular disease. Hypothesis four assessed whether the influence of a previously identified 
functional single nucleotide polymorphism (i.e. -174 G>C) in the promoter region of the IL-6 
gene is associated with circulating levels of both IL-6 and CRP in this healthy, middle-aged 
sample. And hypothesis five examined whether this polymorphism modulates any influence of 
SES on IL-6 and CRP. This discussion examines the results of each aspect of the study in turn, 
with concluding comments at the end.  
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4.1 SOCIOECONOMIC CORRELATES OF INFLAMMATORY MARKERS 
The current study contributes to an understanding of relationships between individual 
SES and inflammatory markers. Consistent with the extant literature (Rathmann et al., 2006; 
Mendall et al., 2000), we found an inverse association between individual SES and plasma IL-6 
that was explained by behavioral factors, including BMI, smoking status and physical activity.  
A large literature supports an association between lower individual SES and poor health 
practices, with higher rates of smoking and obesity and lower levels of physical activity than 
among persons of higher SES (e.g. Marmot et al, 1991). Furthermore, these health practices have 
been associated with higher levels of peripheral proinflammatory mediators (e.g., Bruunsgaard, 
2005; Frohlich et al., 2003). The current findings support a particularly strong relationship 
between BMI and plasma levels of IL-6 and CRP, which may be explained by the production 
and release of IL-6 by adipocytes (Mohamed-Ali et al., 1997). In sum, behavioral covariates of 
individual SES may provide a pathway linking lower SES to increased systemic inflammation.  
In regard to CRP, we found no significant relationship between individual SES and levels 
of CRP after adjusting statistically for age, sex, and race. Although not all findings are consistent 
(Mendall et al, 1997), the current results contrast with increasing evidence of an inverse 
relationship between individual SES and plasma CRP (Owen et al., 2003; Jousilahti, et al., 2003; 
Panagiotakos et al., 2004; Danesh et al., 1999; Wu et al., 2002; Hemingway & Marmot, 1999; 
Rathmann et al., 2000). One possible explanation for our failure to replicate this effect is our 
recruitment of a younger and healthier sample than in many other studies (e.g., Jousilahti et al, 
2003; Panagiotakos et al., 2004; Hemingway & Marmot, 1999). It has also been suggested that 
the presence of subclinical infections among individuals lower in SES may account for 
relationships between individual SES and inflammatory mediators (Mendall et al, 1997). In this 
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regard, we excluded individuals with levels of IL-6 or CRP in the range associated with acute 
infection, decreasing the probability that this confounder could have influenced findings. Finally, 
it is possible that the range of individual SES represented in this sample was limited in 
comparison with other studies. Indeed, 61% of our sample was college educated, with a mean of 
15.3 years of education.  It is possible that a clearer individual SES- inflammatory marker 
relationship would be seen with the inclusion of more individuals from lower socioeconomic 
strata.  
 The present study also provides initial evidence for an association between an 
area-based measure of socioeconomic inequalities and circulating markers of inflammation in a 
relatively healthy, mid-life community sample. Consistent with evidence that socioeconomic 
attributes of communities confer risk for preclinical atherosclerosis (Nordstrom, Diez Roux, 
Jackson & Gardin, 2004; Petersen et al, 2006) and predict cardiovascular morbidity and 
mortality (e.g., Lawlor et al., 2005; Steenland et al, 2004; Booth et al., 2001), our findings show 
that, when compared with residents of more advantaged communities, individuals living in 
census tracts of lower median income, higher rates of poverty and unemployment, and lower 
levels of education have higher levels of plasma CRP and IL-6. These associations were 
independent of individual level SES and of demographic and behavioral health risk factors, 
including age, sex, race, BMI, smoking, alcohol consumption, physical activity and sleep. There 
were no significant community SES by race interactions, and exploratory race stratified analyses 
yielded a similar pattern of results in whites, but results were not significant in blacks. These 
nonsignificant results need to be interpreted with caution, given the small African-American 
sample size (n=197) and consequent power limitations.  
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The current results are consistent with recently published evidence that levels of CRP 
covary inversely with unadjusted community SES (Pollitt et al., 2007), extending these findings 
to show a similar relationship between community SES and IL-6. Thus, our findings also are 
consistent with prior observations that IL-6 concentrations are elevated in 'slum dwellers' when 
compared with the urban middle class in India (Yudkin et al, 1999). Taken together, these 
findings raise the possibility that relationships between community SES and increased 
vulnerability to cardiovascular disease could be mediated, in part, through inflammatory 
pathways.   
The mechanisms through which socioeconomic attributes of communities may affect 
systemic inflammation are unclear. Younger individuals in the sample were more likely to live in 
less advantaged communities than older individuals.  This raises the possibility that community 
SES is a marker of accumulated wealth, which may be a more stable and global socioeconomic 
determinant than indicators of current income and educational attainment. While this 
interpretation is plausible, it suggests that community SES is actually a measure of an individual-
level attribute functioning independently of the physical environment. In all likelihood, 
community SES affects the health of individuals by mechanisms associated with both the 
physical environment and the attributes of the individuals who live there.  
Indeed, a growing literature suggests that community SES is a measure of exposure to 
environmental factors that increase risk for adverse health behaviors as well as a marker of 
access to health promoting resources (Booth et al., 2001). More specifically, physical aspects of 
the environment such as density of fast food restaurants, grocery stores with affordable fruits and 
vegetables, park and recreation facilities, access to medical care, and well lit and safe paths for 
walking are known to vary among neighborhoods, and these physical differences have been 
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shown to impact health behaviors (e.g. Brennan-Ramirez, et al., 2006; Glass, Rasmussen & 
Schwartz, 2006; Morland, Wing, & Diez Roux, 2002; Field et al., 2004; Pearce, Witten & Bartie, 
2006; Roemmich et al, 2006). Further, targeted advertising for alcohol and tobacco use, 
combined with density of convenience stores and alcohol distributors in lower SES 
neighborhoods is associated with enhanced use of these substances  (e.g. Alaniz, 1998; van 
Lenthe & Mackenbach, 2006; Chuang et al., 2005). In sum, physical differences in the 
environment of disadvantaged communities may be one area-level pathway leading to worse 
health behaviors and contributing to increases in inflammatory markers for individuals residing 
there.  
In our study, a number of behavioral risk factors for inflammation were associated with 
lower community SES, including smoking, physical inactivity, less sleep, and higher BMI. These 
findings are consistent with a larger literature showing a number of risk factors for inflammation 
and atherosclerosis to cluster in areas of lower SES. For example, census tract variables 
reflective of social disorganization and urbanization have been shown to predict worse dietary 
habits of youth (Lee & Cubbin, 2002). Community socioeconomic status has been associated 
with smoking behavior in most (Smith et al., 1998; Diez-Roux et.  al., 1997; Reijneveld, 1998 ; 
Sundquist et al., 1998; Duncan et al., 1999), but not all studies (Lee & Cubin, 2002; Hart, Ecob, 
& Smith, 1997).  For example, the odds ratio for current smoking in individuals from lower SES 
communities varies from 1.10 to 1.73 across studies, depending upon which parameters are used 
to index community SES (Diez-Roux et al., 1997; Sundquist et al., 1998).  Individuals in 
deprived areas are less likely to participate in any physical activity (Sundquist et al., 1998), with 
one longitudinal analysis showing residents of poverty areas to experience a decline in physical 
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activity over a 9-year period, irrespective of race or individual income level (Yen & Kaplan, 
1998).   
However, because the association between community SES and inflammatory markers in 
our study was independent of all the behavioral factors we analyzed, theorizing about other 
potential mediating factors is also warranted. There is a longer tradition of examining SES 
mediators at the individual-level, and several studies suggest that lower individual SES is 
associated with psychological and social sequelae, so this discussion will begin with a brief 
review of that literature. For example, individual SES is positively correlated with social support 
and social integration, such that low SES predicts low social support (Rosengren, Orth-Gomer, & 
Wilhemsen, 1998).  Lower SES is also more commonly associated with social isolation than 
higher SES (Turner & Marino, 1994).  People of lower SES report more job strain and effort-
reward imbalance at work, relative to people of higher levels of SES (Bosma, Peter, Siegrist, & 
Marmot, 1998; Marmot, Bosma, Hemingway, et al, 1997). Perceived control and mastery are 
greater among high SES individuals (Bosma, Schrijvers, & Mackenbach, 1999; Lachman & 
Weaver, 1998), and hostility, depression and hopelessness are more commonly associated with 
relative socioeconomic deprivation (Fiscella & Franks, 1997; Gump et al., 1999; Turner & 
Lloyd, 1999).  Finally, people of lower individual SES appear to experience chronic life stress 
(e.g.  health problems of significant others, problems with living conditions, financial stressors) 
more frequently than individuals of higher SES (Lynch, Kaplan, & Shema, 1997; Stronks, van de 
Mheen, Looman, & Mackenbach, 1998; Rozanski et al., 1999). In sum, low individual SES is 
associated with adverse psychosocial profiles, although the direction of the relationship is 
unclear and may, in fact, be bi-directional.  
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Several studies also show that aspects of less advantaged neighborhoods, such as 
crowding, noise, unemployment, and crime contribute to chronic stress burden and other adverse 
psychological sequelae. For example, more stressful life events such as job loss, death of a loved 
one, and criminal victimization are reported in areas with more adverse socioeconomic 
conditions (Fang, Madhavan, Bosworth & Alderman, 1998; Massey & Shibuya, 1995; Krivo & 
Peterson, 1996; Sampson, Raudenbush, & Earls, 1997). In addition to greater exposure to 
stressors in lower SES environments, at least two studies have shown that stress has a greater 
impact on the health of persons living in lower SES neighborhoods (e.g. Boardman, 2004; 
Krieger, 1991), and factors that help to buffer the effects of chronic stress such as social support, 
social integration/cohesion, and informal social control are also worse in lower SES 
environments (e.g. Turner & Marino, 1994; Steptoe & Feldman, 2001). Depression is also more 
prevalent in communities with lower SES (Robert, 1998; Silver, Mulvey & Swanson, 2002; 
Matheson, Moineddin, Dunn, Creatore, Gozdyra, Glazier, 2006).  
Interestingly, Steptoe & Feldman (2001) attempted to more directly address stress that is 
uniquely associated with neighborhoods. They measured both individual and neighborhood SES, 
and then created a "neighborhood problem questionnaire" reflecting variables such as threat from 
others, vandalism, access to amenities, noise, and safety for walking at night. Their results 
showed that these "neighborhood problems" were associated with psychological distress, poorer 
self-rated health, and reduced ability to carry out activities of daily living, arguing that physical 
attributes of the neighborhood environment have a direct correlation with psychological 
outcomes and health. Of note, these associations were independent of both individual and 
neighborhood SES. It is important to conceptualize the potential differences between stress 
related to low individual SES (e.g. unemployment), which might be more easily altered, and 
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stress attributable to neighborhood of residence. The chronic stress burden of living in a lower 
SES community is pervasive, likely longstanding, and wholly outside the individual's control. 
Upward mobility requires stability of employment and an ability to save and plan for the future; 
it is much more complicated than, for example, simply gaining employment that might help put 
food on the table. In this regard, it is easier to conceptualize potential reasons why community 
SES may have more pervasive effects on health than individual SES.    
The pathways for psychological variables, including chronic stress, to affect 
inflammatory markers include both behavioral mediators and more direct psychophysiological 
mechanisms. Behavioral mediators would include, for example, changes in physical activity due 
to depression or stress, resulting in higher BMI and increased production of IL-6 through 
adipocytes. Direct physiological mechanisms include upregulation of innate inflammatory 
processes through endocrine pathways involving the hypothalamic-pituitary adrenal (HPA) axis 
or by activation of the sympathetic nervous system (e.g., Segerstrom & Miller, 2004; Maier & 
Watkins, 1998). More specifically, when the hypothalamus is activated, i.e. by stress, it secretes 
corticotrpoin releasing hormone, which stimulates the release of adrenocorticoptropin releasing 
hormone (ACTH) from the anterior pituitary, in turn triggering cortisol release into the 
bloodstream. White blood cells express receptors for cortisol, which functions to inhibit 
inflammatory processes acutely. With prolonged stress, however, white blood cells may 
downregulate cortisol receptor expression resulting in increased inflammation. Alternatively, 
cortisol secretion itself may diminish, resulting in the same enhanced inflammatory state (Miller, 
Cohen & Ritchey, 2002; Bower, Ganz, Aziz, Olmstead, Irwin, & Cole, 2007). The sympathetic 
nervous system, on the other hand, directly innervates immune organs. The cells of these organs 
express receptors for norephinephrine, a neurotransmitter that is released directly by the 
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sympathetic nervous system. Prolonged secretion of norepinephrine results in increased 
inflammation (Segerstrom & Miller, 2004; Maier & Watkins, 1998).  
4.1.1 Summary 
In sum, this paper provides evidence for an inverse association between individual and 
community SES with inflammatory markers relevant to the development of atherosclerotic 
cardiovascular disease. The association between individual SES and IL-6 was explained by 
adjustment for race, sex, and age, while the association between individual SES and CRP was 
explained by health practices (i.e. smoking, BMI, and physical activity.) Conversely, none of the 
variables we incorporated in these analyses, including individual SES and health practices, 
eliminated the association between community SES and IL-6 or CRP. Older individuals tended 
to live in better communities in our sample. It is therefore possible that community SES 
functions as a more global measure of wealth than individual SES, and is therefore operating as 
an extension of an individual-level attribute. However, evidence from other studies suggests that 
contextual variation in environments affects both the health practices of its individuals, as well as 
the degree of chronic stress to which they are exposed. Furthermore, people living in these 
environments face the added burden of social isolation and lack of community buffers such as 
informal social control and social cohesion, all of which are likely to mediate mental and 
physical health outcomes. 
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4.2 GENETIC INFLUENCES ON IL-6 AND CRP 
Genetic analyses were conducted entering genotype of the polymorphism by three alternative 
groupings. In Caucasian subjects, there was no main effect of the polymorphism on IL-6 levels 
regardless of how 174 G>C was defined. When IL-6 174 G>C was defined by either its three 
genotypes (i.e. GG, GC, CC) or when CC homozygotes were contrasted with any G allele (i.e. 
CG+GG), there was also no main effect of genotype on CRP. However, GG homozygotes had 
lower CRP concentrations than subjects carrying any C allele (i.e. CC+CG). This association 
between dichotomized genotype and CRP seemed to be partially explained by gender and body 
mass index. There was also no evidence of an interaction between either individual or 
community SES and genotype in predicting IL-6 or CRP.  Finally, results in the African-
American subsample showed no association between genotype and IL-6 or CRP.  
 While the 174 G>C polymorphism is thought to be functionally related to the 
production of IL-6 both in-vitro (Fishman et al., 1998) and with circulating IL-6 and CRP in-
vivo (e.g. Fishman et al., 1998; Olivieri et al., 2002; Bonafe, 2001; Jones et al., 2001; Jerrard-
Dunne et al., 2003), not all studies show significant associations (e.g. Endler et al, 2004; Jerrard-
Dunne et al, 2003; Margalionie, et al., 2001; Bennermo et al., 2004; Lieb et al., 2004; Nauck et 
al, 2002; Eklund et al., 2006; Antonicelli et al., 2005), and not all significant findings are in 
agreement. For example, some studies show higher IL-6 and/or CRP in GG homozygotes 
(Fishmann et al., 1998; Olivieri et al., 2002; Bonafe 2001; Nikolova et al, 2007; Libra et al., 
2006), while others suggest either CC homozygotes (Jones et al, 2001) or carriers of any C allele 
are associated with higher IL-6 and/or CRP (D’Aiuto et al., 2004) .  
 These conflicting results may be at least partially explained by haplotype analyses 
showing multiple sites within the promoter region of the IL-6 gene to collectively regulate gene 
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expression (Terry, Loukaci & Green, 2000; Ferrari et al., 2003). For example, one study found 
an additive effect for risk alleles within two sites of the promoter region (i.e. -572G and -174C), 
with each additional risk allele present associated with an increase in production of circulating 
CRP (i.e. presence of 4 risk alleles showed a 79% increase in circulating CRP; Ferrari et al., 
2003). In-vitro haplotype analyses show a much more complicated set of results, such that the 
type of cell line used (i.e. hepatic vs. endothelial) generates a different set of effects. These 
results suggest that regulation of IL-6 by four different sites within the promoter region of the 
gene is not simply additive, but is actually a complex interaction between the alleles of the 
haplotype (Terry et al., 2000).  
 Another potential reason for the largely null findings we have reported includes 
the deviation of our Caucasian subsample’s genotype distribution from Hardy-Weinberg 
equilibrium (HWE).  HWE states that a population’s gene frequencies remain unchanged from 
one generation to the next. A departure from equilibrium could occur due to: genetic drift (i.e. a 
deviation in expected frequencies based on chance, rather than natural selection), migration or 
‘gene flow’ (i.e. permanent movement of genes from one population to another), mutations, non-
random mating, and natural selection operating on this locus. Additionally, study design or 
mechanical problems, such as sampling or genotyping errors, could affect the distribution’s 
conformity with Hardy-Weinberg equilibrium (Hosking et al, 2004). The genetic analyses 
conducted in this paper were based on a subsample of participants (Caucasian n=624) for whom 
we had data on all relevant variables. Because the distribution of genotypes from both the larger 
AHAB database and from those subjects excluded from these analyses (data presented earlier) 
did not deviate from Hardy-Weinberg equilibrium, it is unlikely that the cause of the deviation in 
our subsample was due to genetic drift, mutation, non-random mating, or natural selection. One 
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would expect those effects to also be present in the larger dataset. It is possible that errors in 
genotyping were magnified in this smaller sample, and unfortunately there is no way to confirm 
or disconfirm this hypothesis. Nonetheless, the deviation from Hardy-Weinberg was quite small, 
and additional comparisons show that the Caucasian subsample used in this paper contrasted 
with those subjects from the larger dataset who were not included in these analyses did not differ 
on sex, current marital status, employment status (currently employed vs. not), family income, 
educational attainment, or median community income (ps = ns). They did differ on age, however, 
with a slightly older subsample in these analyses [M = 45.2 years (SD = 6.5) vs 44.0 years (SD = 
7.2); t1043 = -2.93]. Given the lack of significant differences between the two samples, the mild 
deviation from Hardy-Weinberg equilibrium in our subsample is likely due to chance rather than 
forces of natural selection, genetic drift, mutation, assortative mating, or errors in genotyping.   
4.2.1 Gene by Environment Interactions 
Finally, several gene (-174 G>C) by environment (i.e. individual and community SES) 
interactions were tested in this study, and none of the results were significant. A recent article by 
Moffitt, Caspi & Rutter (2005), highlights the conditions under which these authors believe a 
gene by environment interaction is most likely to be discovered. Our study design was consistent 
with many of these conditions. For example, the literature shows heritability for circulating IL-6 
to be estimated at 17-24% (Pantsulaia et al., 2002; de Maat et al., 2004), which is a necessary 
preliminary step before finding a specific gene to study. Secondly, preliminary analyses in the 
AHAB dataset showed a correlation between individual SES and IL-6 to be modest (r = -.16, p < 
.01), showing that individuals exposed to lower SES conditions produce variable IL-6 responses. 
This modest correlation suggests the possibility of a gene by environment interaction. 
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Additionally, Moffitt et al. point out that the environmental risk factor (i.e. SES) should have a 
plausible relationship with a neurobiological pathway for the disorder or trait. In this case, I have 
detailed plausible biological pathways through which SES could affect natural immunity, 
including arousal of the HPA and SAM systems.   
Of particular relevance to this study, Moffitt et al. argue the importance of optimizing 
environmental risk measurement, based partly on proximity of the environmental influence to the 
disorder or trait. In the case of IL-6, previous results show two proximal environmental 
pathogens, i.e. surgery and vaccination, to affect the acute IL-6 response differentially such that 
GG homozygotes had a much higher reaction than those subjects possessing a C allele (Burzotta 
et al., 2001; Travelyan, et al., 2004; Gaudino et al., 2003; Bennermo et al., 2004). We sought to 
extend this research by examining whether a more distal environmental risk factor interacts with 
174 G>C in predicting circulating levels of IL-6 and CRP. It is possible that these distal 
measures of environmental influence (i.e. SES) may not best capture environmental variation 
interacting with -174 G>C, and that a more proximal measure of SES might show different 
results. Such a measure might include an index of chronic stress burden associated with 
residential environment [i.e. neighborhood problem questionnaire, (Steptoe & Feldman, 2001], 
or other measures of chronic stress or depression. If these more proximal moderators vary by 
SES, as we have hypothesized, one might be more likely to discover an interaction with 174 
G>C. 
While it is a reasonable argument that more proximal measures would enhance the 
likelihood of revealing gene by environment interactions, evidence certainly exists that distal 
measures, such as SES, interact with genes in the prediction of phenotypes. For example, two 
studies show that a site on the promoter region of the serotonin transporter gene interacts with 
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individual (Manuck et al., 2004) and unadjusted community SES (i.e. measured by Census data; 
Manuck et al., 2005) in predicting central nervous system serotonergic responsivity. While 
Moffitt et al. argue against using a distal environmental pathogen, then, there is certainly 
precedence in the literature that both community and individual SES interact with genes in the 
prediction of biological traits.  
A final point to consider regarding interpretation of the gene by environment interaction 
findings in this study includes the fact that the environmental pathogen we used, i.e. SES, is 
actually partly heritable. That is, Rowe, Vesterdal, & Rodgers report, for instance, that individual 
difference in IQ, income, and education are all significantly heritable and that a common genetic 
factor accounts for 59% of the covariation between IQ and income and 68% of the covariation 
between IQ and education in one large population study in the US (1999). It is likely, then, that 
SES is not solely environmental (i.e. determined by the political, social, and economic structures 
of a society). Rather, the attainment of a particular SES likely results from a complex interaction 
of personal characteristics, such as intelligence and certain personality variables, as well as 
societal-level variables. In this way, the interactions we tested here may actually be tests of gene 
by gene interactions as well as gene by environment interactions. Nonetheless, believing our null 
findings to be true is challenging given both the power limitations in the stratified analyses, and 
the possibility that our distal measures of SES may have dampened the likelihood of detecting a 
gene by environment interaction.   
4.2.2 Summary of Genetic Influences on IL-6 and CRP 
In sum, analyses examining the relationship between IL-6 174 G>C polymorphism and 
circulating IL-6 and CRP were conducted by three different genotype groupings. Only one 
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significant main effect was found, showing Caucasian subjects carrying any C allele to have 
higher levels of CRP than GG homozygotes. This effect was found in models adjusting for age, 
gender, and SES (i.e. individual or community). When parallel regressions including health 
behaviors, age and sex on step 1, SES (i.e. either individual or community) on step 2, genotype 
on step 3, and genotype by SES on step 4 were executed, the association between genotype and 
CRP was attenuated in both the individual and community SES models (p = .07 and p = .05, 
respectively).  
These findings contribute to an existing literature of conflicting data regarding the 
prediction of circulating IL-6 and CRP based on the -174 G>C polymorphism. Of note, our 
power to detect a significant genetic main effect in this study was limited, particularly in 
African-Americans (i.e. 0.29 in blacks and 0.72 in whites.) Further complicating our 
interpretation of these largely null effects is the mild deviation of our genotype's distribution 
from HWE, which is likely due to chance, but could also be due to a number of other factors 
including errors in genotyping. A more likely explanation for both our null effects as well as the 
conflicting literature on this polymorphism is the reality that both IL-6 and CRP are determined 
by more than one site on the IL-6 gene, and indeed may be influenced by multiple genes. Finally, 
none of our gene by environment interactions were significant, which suggests that the measure 
we used to reflect SES did not interact with -174 G>C in predicting circulating IL-6 or CRP 
levels. However, more proximal measures of SES, such as the neighborhood problem index, or 
indices of chronic stress or depression may have elicited different results.  
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4.3 LIMITATIONS 
There are a number of limitations to the current study. First, its cross-sectional design precludes 
causal interpretation. Alternative explanations for our results showing community SES to be 
associated with inflammatory markers even after adjustment for demographics and health 
behaviors include the possibility that inflammatory mediators and neighborhood of residence are 
independently related to a third factor we did not include in analyses such as personality, 
cognitive ability, or general health. Another limitation is the single assessment of IL-6 and CRP. 
Although evidence suggests that levels of these inflammatory mediators are relatively stable over 
extended periods (e.g. Rao et al., 1994), a more reliable indicator of chronic interindividual 
variability would be derived from multiple assessments over time. Further, because we did not 
screen individuals for acute illness when they presented for the study, we chose to eliminate 
anyone with an IL-6 level greater than 10 pg/mL or CRP level greater than 10 mg/L, which may 
indicate an acute infection. However, it is possible that when we eliminated these subjects we 
also eliminated some subjects with significant chronic inflammation which could have weakened 
our overall findings.  
Regarding genetic analyses, the only significant finding showed GG homozygotes to 
have lower CRP concentrations than carriers of the C allele, which is not without support in the 
literature (D’Aiuto et al., 2004). Obviously, this site on the IL-6 gene is presumed to influence 
circulating CRP through induction of increased IL-6 production. We did not find an association 
between this site and IL-6, however, and given the number of analyses we conducted to obtain 
the significant association between -174 G>C and CRP, the possibility of Type I error must be 
considered.  Also, our choice to examine one site in the promoter region of the IL-6 gene limits 
our understanding of gene by environment interactions. It is possible that SES interacts with 
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other functional polymorphisms on the IL-6 gene to influence circulating inflammatory markers. 
As discussed earlier, using more proximal measures of SES may have also helped detect a gene 
by environment interaction. Finally, race stratified analyses reduced our overall power to detect 
significant genetic effects. The low number of African-American participants (n=187), in 
particular, reduces our confidence in interpreting the null findings (i.e. both SES-inflammatory 
and genetic) from this study.  
4.4 SUMMARY AND FUTURE DIRECTIONS 
Despite these shortcomings, our findings provide initial evidence that socio-demographic 
characteristics of communities are associated with markers of inflammation that are widely 
thought to play a role in the pathogenesis of atherosclerotic cardiovascular diseases. 
Furthermore, these relationships are independent of demographic characteristics, measured 
health practices and socioeconomic attributes of individuals, raising the possibility that 
inflammatory mechanisms mediate relationships between community SES and increased 
vulnerability to cardiovascular disease. The -174 G>C polymorphism was also unrelated to 
circulating IL-6, while the C allele predicted higher levels of circulating CRP. This association 
was partially mediated by gender and BMI.  
Future studies should prospectively investigate the role of both individual and community 
SES on inflammation, and attempt to address other possible mechanisms that might account for 
this relationship, including psychological activation of hypothalamic-pituitary-adrenal (HPA) 
and autonomic nervous system  (ANS) pathways. Studies should begin in early adulthood, before 
significant atherosclerotic disease develops. A focus on more proximal neighborhood 
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characteristics such as access to health resources (i.e. parks, healthy food), density of fast food 
restaurants, violence/crime, and noise, and an examination of the psychological sequelae of 
living in these environments (i.e. chronic stress) would help inform the complex interaction of 
community effects on individual psychology and health. These proximal measures of 
neighborhood environment might also increase the likelihood of finding gene by environment 
interactions. These genetic studies should also have more subjects to optimize power.  
Investigation of resiliency factors such as social support, social integration, and exercise would 
also be informative. Since cardiovascular disease, and many of its risk factors, are more 
prevalent in African-Americans, additional investigation of the role of inflammation in racially 
diverse populations is warranted (Albert & Ridker, 2004).   
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